rfhg_15873.1

Basic information about the TSS

---

TSS ID: rfhg_15873.1 Species: human Chr: chr1		Start: 171539967 End: 171539967 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AB029019:294 GeneID: 23215 HGNC/MGI_ID: HGNC:24903 UniProt_ID: Nearer transcript ids and distances:

Gene_name: proline rich coiled-coil 2C Gene_symbol: PRRC2C Gene_synonyms: KIAA1096 XTP2 Gene_source: HGNC:24903

TATA-Box annotation

---

Distance to TSS:	54437
Nearest PromoterID:	NM_015172
Entrez ID:	23215
Nearest Unigene:	Hs.494614
Nearest Refseq:	NM_015172
Nearest Ensembl:	ENSG00000117523
Gene Name:	proline rich coiled-coil 2C
Gene Alias:	BAT2-iso|BAT2D1|BAT2L2|XTP2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PRRC2C p2@PRRC2C p3@PRRC2C p4@PRRC2C p5@PRRC2C p6@PRRC2C p8@PRRC2C p10@PRRC2C
Sample		p1@PRRC2C	p2@PRRC2C	p3@PRRC2C	p4@PRRC2C	p5@PRRC2C	p6@PRRC2C	p8@PRRC2C	p10@PRRC2C
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	142.21	13.05	7.99	7.99	3.12	7.21	4.48	4.29
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	130.70	12.34	4.86	8.50	3.03	8.90	5.26	2.43
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	151.62	14.66	11.77	10.03	5.21	10.42	7.52	4.24
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	139.30	9.36	4.16	6.86	2.29	5.61	3.12	3.53
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	138.35	10.57	5.17	7.87	2.70	7.42	2.02	3.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	141.68	11.24	7.36	8.72	3.68	9.50	2.91	2.91
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	184.33	17.65	11.33	12.64	5.23	9.15	3.92	5.66
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	158.17	14.78	2.66	6.06	1.94	8.48	3.39	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	145.75	12.82	3.85	4.92	1.07	6.84	1.71	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	190.12	11.59	4.64	3.48	2.32	5.80	1.16	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	164.93	12.13	6.47	4.85	1.21	8.08	2.43	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	179.70	14.64	4.07	2.85	1.63	7.72	2.03	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	55.29	9.99	0.81	1.13	0.97	3.71	0.81	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	55.93	7.37	1.35	2.56	0.60	1.50	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	58.18	7.46	1.32	2.20	0.66	2.63	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	55.33	8.05	1.26	1.26	0.50	6.79	1.01	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	47.83	7.86	1.31	1.09	0.44	3.49	1.31	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	48.09	4.22	2.53	3.80	1.27	8.86	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	54.38	8.00	1.07	1.07	0.00	2.13	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	59.57	5.42	1.20	0.75	1.20	3.61	1.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	57.20	7.35	1.87	1.74	1.07	6.01	1.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	59.90	5.01	1.73	2.07	1.38	4.49	1.38	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	55.97	7.37	1.29	0.78	0.78	3.88	0.90	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	61.15	5.82	1.21	0.73	1.21	5.82	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	62.18	6.71	0.77	2.06	0.77	4.13	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	65.52	5.70	1.27	1.58	0.63	4.43	1.58	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	76.37	9.34	2.20	1.10	0.55	6.04	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	81.81	9.19	2.59	4.95	0.94	3.54	3.06	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	64.61	6.95	1.78	1.45	1.29	6.30	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	68.22	7.24	2.53	1.99	1.45	2.90	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	72.64	6.49	1.05	2.51	0.63	5.23	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	72.10	7.62	1.37	0.98	1.37	5.47	0.78	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	66.69	6.54	2.53	2.53	1.06	11.61	1.06	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	101.44	11.38	2.47	2.14	0.99	8.08	1.32	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	67.88	8.60	2.62	2.06	0.93	4.30	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	75.69	8.81	2.68	1.72	2.49	3.64	1.92	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	77.26	8.79	3.27	1.64	0.61	6.13	1.64	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	72.33	6.25	2.01	1.81	1.41	4.84	1.41	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	76.71	10.80	1.62	3.51	1.62	5.67	1.35	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	70.82	6.72	2.16	2.40	0.24	5.52	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	64.23	6.12	1.18	1.88	1.88	3.53	1.88	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	87.98	10.39	3.07	1.61	1.02	5.56	0.88	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	73.18	10.54	1.48	2.74	1.05	5.48	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	82.52	8.57	2.45	1.40	0.35	7.34	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	92.96	7.83	1.81	2.41	2.41	2.41	1.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	93.29	8.38	2.09	2.56	1.86	7.21	2.33	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	77.97	9.12	0.72	1.44	1.68	5.28	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	79.28	7.75	2.09	1.19	1.79	6.56	1.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	86.17	11.01	1.91	0.96	1.20	5.74	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	89.37	10.51	1.82	1.01	1.01	3.24	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	97.15	9.43	2.05	2.46	1.43	7.99	2.05	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	103.40	15.79	2.45	4.45	2.22	6.67	2.45	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	853.52	125.93	321.82	363.80	335.81	111.94	55.97	111.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	101.84	11.00	1.06	1.77	1.42	4.61	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	77.88	10.94	0.33	0.99	0.66	3.65	2.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	311.25	32.72	22.65	22.65	11.75	44.46	21.81	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	143.28	20.67	5.05	5.97	3.67	15.15	4.59	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	89.78	6.48	1.30	2.59	0.32	5.51	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	82.22	10.92	1.28	2.25	0.64	5.14	0.96	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	118.82	15.40	3.77	5.97	1.57	10.37	4.09	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	90.25	14.81	1.41	0.00	2.12	4.23	2.82	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	89.73	10.09	1.12	2.80	0.00	4.49	3.36	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	207.00	23.88	17.52	20.70	11.15	24.68	11.15	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	114.50	15.97	4.08	6.12	2.72	12.57	2.38	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	93.90	13.65	2.27	2.27	0.65	7.47	3.25	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	86.61	10.29	1.77	2.13	0.35	4.97	2.13	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	872.85	129.31	436.43	404.10	274.79	32.33	64.66	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	584.41	78.97	229.03	213.23	221.13	78.97	39.49	63.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	69.23	8.78	2.93	0.98	0.49	2.93	0.98	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	73.88	7.93	2.48	1.49	0.99	2.48	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	60.52	8.91	2.35	0.47	1.41	2.81	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	76.50	7.29	1.66	1.66	0.00	4.64	2.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	75.48	10.21	1.55	2.78	1.86	4.02	1.24	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	66.04	8.56	3.36	1.83	0.31	1.22	0.92	0.92
Adipocyte - breast, donor1	11376-118A8	43.71	7.44	0.95	0.48	0.00	0.63	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	39.30	5.94	3.53	2.25	1.76	2.09	2.41	0.64
Adipocyte - omental, donor1	11473-119C6	64.00	10.69	1.40	0.13	1.15	1.40	0.64	0.25
Adipocyte - omental, donor2	11474-119C7	33.64	2.24	1.49	0.75	0.00	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	37.18	7.37	0.67	0.33	0.00	1.34	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	35.73	1.91	0.00	1.91	0.00	1.28	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.23	7.23	0.00	0.00	0.90	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	24.50	4.00	2.78	0.70	0.52	0.35	0.52	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	89.18	17.01	0.20	0.78	1.17	0.78	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	74.64	10.55	1.29	0.77	0.77	1.29	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	74.15	11.43	0.84	0.56	0.84	0.28	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	94.64	10.58	2.35	0.00	0.59	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	85.74	11.90	1.37	0.32	0.72	0.72	0.40	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	87.79	11.62	0.97	0.00	0.97	0.97	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	69.85	8.00	1.07	1.07	0.00	1.60	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	72.34	10.02	1.11	0.56	0.56	1.11	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	32.02	4.57	0.00	0.00	0.42	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	53.75	9.04	1.76	0.50	0.25	0.75	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	52.36	8.51	0.33	0.33	0.00	0.00	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	52.06	6.70	0.61	0.30	0.00	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	20.33	3.31	0.88	0.66	0.22	0.22	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	25.82	4.30	0.36	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	0.00	1.20	0.00	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	44.26	7.02	1.08	0.36	0.54	0.72	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	29.58	3.49	0.82	0.21	0.21	0.00	0.41	0.82
Anulus Pulposus Cell, donor1	11248-116E6	42.45	5.72	2.17	1.03	1.26	1.03	1.49	0.69
Anulus Pulposus Cell, donor2	11463-119B5	52.17	7.35	1.71	0.98	0.24	1.71	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	48.07	5.84	0.90	0.45	0.00	2.25	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	41.68	4.34	3.91	1.30	0.87	0.87	1.74	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	2.14	4.28	8.56	0.00	6.42	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	43.94	3.29	2.39	1.49	0.60	2.69	1.79	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	32.88	5.06	2.53	0.00	2.53	2.53	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	36.30	2.64	1.32	0.66	1.32	0.66	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	44.51	5.20	0.65	1.30	0.65	1.95	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	36.41	2.91	1.94	2.43	1.94	0.49	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.76	5.34	2.97	2.38	0.00	0.59	2.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	41.43	3.39	1.13	1.13	0.00	1.88	1.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	38.46	7.26	1.45	4.35	0.00	0.73	1.45	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	0.00	0.00	1.25	0.00	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	33.44	5.27	0.33	0.16	0.00	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	43.67	5.46	1.36	2.73	0.00	0.00	1.36	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.74	3.92	0.30	0.30	0.15	0.00	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	33.75	3.75	2.14	0.54	1.07	2.68	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	35.14	5.67	0.94	1.13	0.19	0.76	1.13	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	42.77	4.01	2.67	0.80	1.87	0.27	2.14	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	31.21	0.98	0.00	1.95	0.98	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.36	3.65	1.33	1.16	0.33	0.66	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	28.82	2.40	0.00	0.00	0.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	39.97	7.20	3.26	2.06	1.20	1.72	1.54	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	50.34	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	37.86	1.46	0.49	1.94	2.43	2.43	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	44.78	5.31	1.52	0.76	0.00	1.90	0.38	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	1.21	1.21	0.00	0.00	3.63	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	26.79	4.56	0.57	0.00	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	37.62	4.92	1.07	0.21	0.64	0.43	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.78	4.39	0.52	0.52	1.55	0.52	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	32.38	1.41	1.41	2.82	0.94	0.94	0.47	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	38.91	2.89	2.25	1.93	0.96	1.29	1.29	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	32.11	1.43	0.00	2.14	0.71	0.71	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.17	1.17	1.17	2.34	0.00	2.34	1.17	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	42.75	3.01	1.51	1.20	1.81	0.90	1.20	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	33.26	2.38	1.19	0.00	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	38.65	5.59	0.51	1.53	0.00	1.53	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	42.02	3.57	2.80	2.80	1.27	2.80	2.29	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	3.81	0.64	0.64	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	30.64	4.75	0.86	1.29	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	36.62	3.81	1.06	0.42	0.42	1.27	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.62	3.77	1.16	0.58	0.29	0.00	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	39.68	6.61	1.89	0.94	0.94	0.94	0.00	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	30.68	5.09	1.70	0.51	0.51	0.85	1.19	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	2.32	4.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	44.36	6.34	0.00	0.00	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	44.60	4.50	1.93	0.64	0.86	1.07	0.64	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	36.10	6.02	3.01	3.01	1.80	1.20	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	32.80	3.64	2.92	0.73	1.46	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	39.08	2.53	1.15	0.46	0.92	1.61	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	40.80	2.55	2.55	2.55	2.55	2.55	0.00	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.88	5.85	1.02	0.00	0.00	0.25	1.02	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	39.84	6.40	1.03	0.83	0.21	0.41	1.03	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	33.66	3.67	3.37	1.84	0.31	0.92	1.53	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	62.14	1.91	1.43	2.87	1.43	1.91	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	34.59	3.77	2.66	1.77	0.22	1.33	1.77	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	1.53	0.00	1.53	0.00	1.53	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	33.23	6.65	0.00	1.11	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	40.51	6.88	2.65	3.44	1.06	0.79	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	38.89	6.18	0.00	0.73	1.09	0.00	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	40.90	7.37	0.37	0.49	0.49	0.37	0.25	0.74
Astrocyte - cerebellum, donor2	11580-120F5	35.60	3.94	0.34	0.34	0.17	0.00	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	21.39	2.73	0.42	0.00	0.21	0.42	0.42	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	84.71	11.15	3.14	2.09	1.74	1.39	2.09	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	109.20	10.68	7.60	4.85	3.56	3.56	3.56	2.59
Astrocyte - cerebral cortex, donor3	11392-118C6	100.98	12.38	4.03	2.68	2.39	2.09	1.04	1.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	259.88	45.30	8.72	4.82	7.57	9.75	6.77	3.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	263.84	45.23	12.03	4.89	5.64	7.14	5.01	2.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	266.06	43.81	9.45	5.92	5.58	7.40	5.12	3.64
Basophils, donor1	12241-129G9	117.69	10.46	2.62	0.52	1.31	0.52	0.26	0.26
Basophils, donor2	12242-129H1	323.63	35.00	0.36	0.72	0.72	1.44	0.72	0.00
Basophils, donor3	12243-129H2	116.72	14.41	2.79	0.44	1.32	0.73	0.15	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	21.56	3.23	0.65	0.22	0.43	0.43	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	18.29	3.20	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	28.69	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	42.68	6.28	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	42.63	3.54	0.00	0.00	0.00	0.00	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	39.38	4.61	0.46	0.46	0.46	0.00	0.46	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	50.02	10.26	5.58	3.60	5.22	1.80	4.32	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	144.28	16.59	7.63	3.92	4.33	2.47	3.40	1.96
Burkitt's lymphoma cell line:RAJI	10476-106I8	216.60	30.04	23.06	10.71	16.54	5.36	4.89	4.66
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	109.68	11.19	1.28	0.32	0.00	0.64	1.28	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	20.68	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	203.44	20.29	4.51	3.38	1.13	3.38	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	253.16	19.86	29.88	8.91	10.02	5.38	6.31	5.75
CD14+ Monocytes, donor3	11381-118B4	191.66	22.39	20.86	8.34	11.85	3.29	2.85	3.51
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	117.18	12.45	0.85	1.13	0.28	1.98	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	134.19	21.61	2.65	1.52	0.00	1.52	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	163.71	22.68	1.97	0.66	0.66	0.00	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	160.74	13.01	9.97	5.20	6.50	6.07	3.61	2.17
CD14+ monocytes - mock treated, donor2	11873-125C1	145.14	12.67	9.05	3.02	4.83	3.32	1.81	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	189.04	18.71	14.69	5.92	3.08	2.84	1.66	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	143.46	15.74	9.88	4.52	3.85	4.35	1.34	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	155.39	19.87	16.84	6.62	6.35	3.31	1.93	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	207.52	15.12	13.88	7.69	5.21	3.72	2.48	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	168.19	15.86	13.51	6.85	5.29	5.48	2.15	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	201.55	17.09	11.57	5.16	3.38	6.23	0.89	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	220.02	16.76	4.57	3.26	1.09	2.61	1.74	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	195.50	16.15	8.90	2.11	3.75	2.81	2.34	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	319.46	27.46	8.98	10.56	2.64	1.58	3.70	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	271.79	24.41	9.98	5.55	3.33	1.11	3.33	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	142.50	15.47	12.64	8.63	6.84	4.76	4.61	3.27
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	159.24	17.76	10.38	6.98	5.19	4.59	2.00	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	166.77	15.82	5.62	2.29	2.71	1.67	1.25	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	225.58	18.07	8.92	6.41	7.55	6.41	3.20	3.89
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	266.24	26.01	8.60	2.94	2.49	1.81	1.36	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	235.25	20.08	12.22	6.55	6.11	3.49	3.06	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	215.19	17.22	7.80	2.96	4.03	4.84	1.61	2.69
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	206.04	15.88	16.92	5.58	8.37	5.76	2.44	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	238.61	27.35	13.89	8.42	6.31	3.79	2.10	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	222.84	17.64	23.33	18.37	12.68	7.90	8.63	6.98
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	298.72	22.90	22.54	6.34	8.45	4.58	4.58	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	377.74	32.47	23.69	7.90	7.46	5.70	3.51	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	190.77	15.52	27.90	12.21	9.94	7.15	5.75	4.18
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	178.40	21.56	29.36	16.73	12.27	6.69	6.69	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	229.99	22.85	8.84	1.94	2.37	1.72	1.29	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	174.44	15.15	14.33	11.47	7.78	6.14	2.05	4.09
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	300.64	26.43	6.72	3.01	3.01	1.85	1.39	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	302.52	26.68	9.74	5.10	2.09	3.71	2.55	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	82.61	10.24	1.96	0.65	0.44	0.44	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	89.63	9.93	2.08	0.69	1.39	0.46	1.39	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	60.44	9.75	1.08	1.73	1.08	0.22	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	129.72	16.20	1.87	2.34	0.93	0.47	0.93	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	97.98	11.70	2.27	2.27	1.05	1.05	1.40	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	263.55	28.32	10.03	3.79	1.78	3.12	1.34	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	80.64	12.76	1.02	2.55	0.51	1.28	1.28	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	74.65	11.64	3.51	1.98	1.54	1.10	1.32	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	80.43	12.42	0.63	1.68	0.42	0.42	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	115.84	22.36	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	153.22	18.98	2.71	1.36	3.39	2.03	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	155.34	25.89	1.04	1.04	1.04	1.04	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	142.85	19.72	2.67	3.20	1.07	1.60	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	158.14	18.76	1.61	1.07	0.54	0.00	2.68	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	154.43	23.16	0.70	0.00	1.40	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	131.77	26.67	0.78	0.00	0.00	0.78	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	187.20	19.77	0.00	2.64	1.32	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	546.56	51.78	23.01	16.44	13.97	8.22	11.51	5.75
CD19+ B Cells, donor2	11624-122B4	577.44	74.72	22.49	11.61	15.23	8.71	11.61	6.53
CD19+ B Cells, donor3	11705-123B4	542.18	54.52	20.19	7.57	9.09	10.10	8.08	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	124.05	22.22	8.08	0.81	2.42	0.40	2.02	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	69.91	7.99	0.80	0.40	0.40	0.40	0.80	1.60
CD34+ Progenitors, donor1	11545-120B6	140.57	21.09	3.01	0.00	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	320.23	29.78	3.37	0.56	1.12	1.12	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	84.17	13.90	0.75	0.38	0.38	0.75	1.50	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	112.74	14.21	0.68	0.68	0.45	0.23	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	712.33	66.41	40.35	17.85	17.50	6.43	4.64	7.50
CD4+ T Cells, donor2	11306-117C1	540.72	39.80	63.69	30.01	26.33	22.05	25.11	19.60
CD4+ T Cells, donor3	11382-118B5	483.41	39.34	36.90	24.40	17.08	7.93	10.37	8.84
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	199.34	34.46	4.08	1.53	1.02	1.28	1.53	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	205.51	29.42	4.27	2.92	1.35	1.57	1.57	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	193.17	33.92	4.31	1.72	1.72	1.44	1.44	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	303.89	27.02	6.16	5.22	1.42	1.42	4.27	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	283.04	40.03	9.13	4.21	0.00	0.70	0.70	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	336.21	29.67	0.00	3.30	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	163.59	26.59	3.76	2.17	1.59	1.45	0.87	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	164.04	25.08	9.32	11.18	4.41	4.07	2.88	2.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	160.88	25.31	10.48	8.06	3.71	2.26	4.03	4.03
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	202.18	18.38	3.14	0.90	0.00	0.45	1.79	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	187.62	22.36	2.80	2.45	1.75	1.75	3.14	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	329.11	50.60	7.48	11.00	6.16	3.08	1.32	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	233.59	29.09	5.90	3.37	1.69	2.11	2.11	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	147.93	19.74	8.31	11.43	4.36	1.87	3.32	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	127.30	16.04	5.01	6.68	1.67	2.67	2.34	3.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	359.23	38.61	4.89	5.98	4.62	3.54	2.45	2.45
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	371.95	43.95	2.68	2.14	1.07	2.14	2.68	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	320.99	34.07	5.38	8.97	1.79	3.59	7.17	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	196.74	27.44	5.01	3.71	2.04	1.85	3.34	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	144.05	19.28	2.60	3.47	1.95	1.52	3.03	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	169.38	26.69	2.10	1.89	1.05	0.84	1.26	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	231.57	19.72	5.06	3.03	0.00	2.53	4.04	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	186.73	23.40	3.47	1.73	0.00	1.73	3.03	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	395.72	59.27	9.59	8.72	7.41	6.10	2.61	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	216.26	23.75	4.95	1.48	0.99	0.49	1.48	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	169.87	24.00	3.69	3.69	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	187.04	30.71	1.40	2.79	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	317.64	42.37	1.66	1.11	0.55	0.55	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	420.60	59.63	2.45	2.45	0.98	1.96	0.25	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	254.10	49.28	4.62	3.08	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	238.86	30.80	2.51	0.72	0.72	0.36	2.15	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	195.28	31.85	2.77	1.38	0.00	2.77	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	491.09	37.32	24.23	12.11	10.15	6.88	2.62	5.89
CD8+ T Cells, donor2	11307-117C2	424.24	33.04	43.93	26.28	18.40	14.64	13.89	9.76
CD8+ T Cells, donor3	11383-118B6	534.27	46.96	46.46	24.24	23.23	10.60	11.36	11.11
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	92.44	18.12	4.59	7.11	1.61	4.36	4.59	2.98
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	100.41	19.17	9.11	5.75	3.83	7.67	5.03	3.35
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	116.82	20.52	6.29	8.75	1.64	5.20	4.38	3.01
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	135.40	32.42	4.50	5.40	3.30	4.20	2.70	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	101.51	22.80	7.44	6.96	2.88	4.56	3.84	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	108.01	22.74	2.96	4.32	1.36	5.91	0.91	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	90.17	19.77	4.56	4.78	1.09	4.78	1.52	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	111.34	20.27	2.90	4.74	1.32	5.00	1.58	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	99.43	26.03	3.28	3.75	4.22	4.22	2.11	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	96.90	18.72	3.92	9.06	3.92	6.34	3.92	3.62
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	113.59	17.72	4.65	3.49	3.49	4.65	3.20	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	94.32	23.18	3.46	2.40	2.13	2.66	2.66	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	90.61	23.20	3.06	1.75	1.31	1.31	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	120.69	29.15	4.10	2.73	2.73	1.37	0.91	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	124.56	27.60	2.98	0.75	2.24	3.73	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	83.56	21.97	2.16	3.24	0.36	1.80	1.44	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	94.08	22.73	3.16	3.45	1.44	1.73	2.59	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	85.56	18.86	2.12	1.41	0.00	1.18	0.94	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	117.57	33.59	3.80	5.39	1.90	3.49	0.95	3.17
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	102.73	30.76	3.69	4.31	1.54	4.61	1.23	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	98.42	21.48	3.21	2.56	1.60	2.56	0.96	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	101.74	25.63	3.82	6.50	3.06	4.97	1.91	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	97.74	22.07	4.34	3.94	1.18	2.36	1.97	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	95.31	17.40	4.54	3.78	1.51	3.78	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	211.18	46.57	4.01	5.62	4.01	4.82	4.01	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	215.42	51.06	5.60	9.09	2.80	9.09	1.40	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	217.38	57.10	17.03	7.01	7.01	8.01	3.01	4.01
Cardiac Myocyte, donor1	11525-119I4	58.49	7.31	27.42	5.48	7.31	21.93	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	42.00	5.93	0.49	0.99	0.99	3.46	1.98	0.49
Cardiac Myocyte, donor3	11686-122I3	26.41	2.32	0.32	0.42	0.00	0.00	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	67.95	13.87	2.08	2.08	0.69	1.39	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	31.63	4.62	0.00	0.00	0.71	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	32.31	5.23	4.89	1.59	2.84	3.07	1.82	1.48
Chondrocyte - re diff, donor2	11339-117F7	134.29	18.80	0.90	0.00	0.00	0.90	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	35.18	6.47	2.43	0.40	0.40	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	125.55	16.18	4.93	1.84	1.61	1.15	1.84	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	79.95	10.26	5.99	3.21	3.42	1.71	2.99	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	92.04	10.44	5.84	3.19	2.48	1.59	2.57	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	86.29	15.96	1.19	0.46	1.28	0.92	0.92	0.73
Corneal Epithelial Cells, donor1	11526-119I5	13.61	2.20	0.22	0.44	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	40.95	7.96	1.14	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	29.91	4.35	0.26	0.51	0.51	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	101.70	16.84	4.13	0.99	1.65	0.50	0.33	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	91.15	17.03	2.52	0.32	1.26	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	10.35	3.45	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	58.64	8.10	2.16	1.84	1.30	1.30	1.19	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	188.24	19.82	4.44	1.37	1.37	1.71	1.37	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	201.74	13.71	1.96	1.31	0.00	1.31	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	245.84	26.62	2.90	1.45	0.00	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	38.69	6.17	0.17	0.00	0.17	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	45.18	7.04	0.59	0.00	0.00	0.00	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	31.39	4.24	1.98	0.28	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	44.43	3.93	0.79	0.00	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	42.76	3.78	0.87	0.29	0.87	0.00	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	90.11	5.88	3.53	3.06	2.35	2.12	3.76	1.65
Endothelial Cells - Artery, donor3	11413-118E9	67.32	6.14	0.88	0.53	0.18	0.18	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	83.34	12.86	1.11	1.55	1.11	0.89	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	101.02	12.78	2.43	0.61	0.91	0.61	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	113.89	14.94	2.26	0.28	1.69	1.13	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	32.68	5.35	0.30	0.30	0.59	0.00	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	37.49	6.77	0.00	1.04	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	23.54	3.97	1.56	0.85	0.85	0.43	1.28	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	128.84	15.60	2.00	0.00	0.40	0.80	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	51.36	6.29	0.00	1.05	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	179.04	17.39	2.48	2.48	1.49	0.62	1.49	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	112.54	9.99	1.52	0.65	0.00	1.30	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	128.60	14.04	3.05	1.10	1.10	2.32	1.22	0.49
Endothelial Cells - Vein, donor1	11267-116G7	36.40	2.28	1.14	0.00	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	33.53	5.59	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	52.28	5.02	2.67	0.94	0.94	0.79	1.26	0.16
Eosinophils, donor1	12244-129H3	213.46	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	453.82	47.86	14.85	1.65	4.95	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	378.08	57.07	21.40	7.13	10.70	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.19	3.18	0.00	0.73	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	4.16	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	75.53	14.37	4.11	1.64	0.82	2.46	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.04	3.07	0.99	0.33	0.11	1.75	0.99	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	22.10	2.49	0.54	0.54	0.11	3.36	0.54	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	65.01	8.13	2.18	1.94	1.46	1.21	2.06	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	126.65	21.56	2.46	1.50	2.05	1.23	0.68	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	43.03	7.28	1.58	2.11	0.74	1.79	1.37	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	179.44	25.03	4.74	3.16	2.90	2.90	2.11	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	64.11	9.97	3.65	1.99	2.66	1.99	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	45.36	4.54	0.45	0.91	0.00	0.91	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	43.96	6.06	0.76	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	34.38	4.89	1.10	0.32	0.63	0.63	0.63	0.47
Fibroblast - Cardiac, donor4	11452-119A3	97.30	19.70	1.52	0.91	1.21	0.61	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	84.01	10.91	0.89	0.63	0.63	0.63	1.14	0.63
Fibroblast - Cardiac, donor6	11460-119B2	92.17	9.55	0.45	0.45	0.30	1.52	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	56.81	6.97	0.94	0.00	0.54	0.54	0.13	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	92.33	12.08	2.59	1.29	0.86	4.31	3.02	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	5.86	5.86	2.93	4.39	5.86	4.39	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	42.21	4.84	1.38	0.92	0.46	0.23	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	62.41	7.97	3.05	1.02	0.51	1.02	0.85	1.36
Fibroblast - Dermal, donor1	11269-116G9	36.16	5.63	1.17	0.47	0.94	0.70	1.17	0.47
Fibroblast - Dermal, donor2	11346-117G5	42.45	7.08	0.94	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	35.78	6.17	5.80	3.99	3.87	2.30	1.45	0.60
Fibroblast - Dermal, donor4	11450-119A1	93.71	9.95	0.90	0.11	0.34	1.58	0.45	0.45
Fibroblast - Dermal, donor5	11454-119A5	114.79	12.39	0.70	1.05	0.17	1.22	0.87	0.52
Fibroblast - Dermal, donor6	11458-119A9	129.94	15.43	0.81	0.16	0.16	1.79	1.30	0.32
Fibroblast - Gingival, donor1	11237-116D4	92.25	13.12	0.21	0.62	0.21	0.42	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	91.18	9.96	3.41	1.31	1.05	0.52	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	92.51	11.60	6.06	3.82	3.16	3.43	3.95	3.82
Fibroblast - Gingival, donor3	11394-118C8	81.31	12.76	1.16	0.58	0.58	1.16	0.58	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	62.33	8.31	1.04	2.08	1.04	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	39.12	3.88	3.35	3.00	0.88	1.94	1.23	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	108.04	14.19	4.99	3.90	2.65	2.03	1.87	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	79.65	11.63	2.16	2.30	1.49	1.22	0.81	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	30.35	3.88	0.00	0.00	0.00	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	87.60	8.92	1.46	1.46	1.02	1.75	1.17	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	100.77	11.18	2.59	2.73	2.05	1.09	0.95	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	117.48	10.64	4.28	1.76	1.10	1.21	0.66	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	87.46	10.71	2.49	1.03	1.17	1.76	0.59	0.59
Fibroblast - Lung, donor1	11270-116H1	19.03	5.44	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	86.54	16.41	4.48	0.00	4.48	4.48	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	49.38	4.85	1.48	0.63	0.21	1.27	1.06	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	42.48	7.50	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	4.20	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.44	2.24	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	62.11	10.96	0.00	0.00	0.41	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	23.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	11.91	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	87.09	15.91	4.46	2.52	1.55	1.55	0.78	1.75
Fibroblast - Periodontal Ligament, donor2	11319-117D5	130.29	16.99	3.03	1.37	1.82	2.88	2.28	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	143.20	29.07	1.53	0.00	0.31	0.00	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	60.68	8.01	1.53	0.76	0.38	1.53	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	45.90	5.13	0.54	0.27	0.54	0.54	1.35	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	40.47	4.64	0.93	0.46	0.12	0.46	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	30.29	4.75	1.55	0.99	0.33	0.77	0.33	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	38.81	6.50	1.02	0.20	0.20	0.20	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	46.77	2.67	1.34	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	39.54	3.16	0.79	0.40	0.00	0.00	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	266.71	36.12	14.09	12.90	5.36	11.71	3.37	3.77
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	52.40	7.99	2.84	1.78	1.60	0.53	1.95	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	56.76	10.84	2.37	2.96	1.77	1.38	0.59	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	151.33	18.95	3.01	4.21	1.20	3.31	1.20	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	97.26	14.25	1.30	0.86	0.65	0.54	0.65	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	126.54	17.46	5.06	2.53	1.52	4.05	0.25	1.01
Fibroblast - skin normal, donor1	11553-120C5	52.18	7.55	1.80	1.80	1.31	1.15	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	204.72	33.48	6.62	4.21	3.81	3.21	2.01	2.41
Fibroblast - skin normal, donor2	11561-120D4	76.15	11.55	1.51	0.60	0.40	0.50	0.50	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	203.71	30.22	8.76	6.04	4.23	10.88	2.12	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	64.62	9.36	1.16	0.91	0.66	0.75	0.66	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	118.30	17.78	3.08	1.71	0.85	1.88	1.37	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	151.41	22.00	6.24	2.96	1.97	3.94	0.99	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	79.47	12.14	2.02	0.96	0.43	0.85	0.85	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	55.66	7.93	1.35	1.52	1.01	2.19	0.51	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	36.23	3.92	0.31	0.63	1.25	2.67	1.57	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	465.36	66.48	22.16	44.32	0.00	132.96	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	154.26	14.82	2.61	0.87	0.87	5.23	2.61	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	69.00	10.57	1.56	0.69	0.69	0.87	0.87	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	95.25	13.53	2.86	0.52	1.56	0.78	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	107.06	17.63	1.79	0.77	1.02	0.51	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	67.37	8.42	1.53	1.53	1.53	3.83	4.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	120.60	11.49	2.55	2.55	0.00	1.91	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	220.79	20.82	10.27	7.99	3.14	8.27	6.28	4.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	146.98	13.51	10.20	9.10	4.96	5.24	3.58	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	123.98	16.90	5.25	4.79	2.97	2.28	3.88	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	160.68	14.66	8.32	5.35	1.98	7.13	2.97	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	137.19	14.27	4.76	5.82	3.17	5.55	2.91	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	106.32	14.35	4.89	3.91	1.30	1.30	1.96	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	183.08	16.80	11.06	8.40	6.19	11.06	6.19	6.63
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	134.82	11.31	7.63	4.95	3.53	3.82	4.10	1.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	128.19	13.79	9.11	4.06	3.32	2.83	3.69	2.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	125.18	13.97	8.86	4.30	3.22	4.30	2.95	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	101.34	8.80	6.69	3.96	4.09	3.10	2.35	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	115.31	13.01	5.40	2.77	3.60	2.91	2.91	2.21
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	134.38	15.25	6.91	4.88	5.08	3.25	3.05	2.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	85.34	7.07	5.25	3.65	1.83	2.97	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	90.06	10.46	5.85	2.87	1.37	1.87	2.49	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	119.34	18.14	6.99	3.72	3.28	2.62	2.19	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	80.37	9.46	4.43	2.36	2.36	1.77	2.07	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	106.34	10.17	6.36	4.45	3.97	2.54	2.86	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	105.01	13.41	5.36	3.13	2.68	2.23	2.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	101.62	9.48	3.83	3.23	2.82	3.43	3.02	2.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	108.57	13.06	8.65	4.75	3.56	2.88	3.22	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	163.60	19.77	3.19	2.04	2.04	2.31	1.33	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	150.26	17.90	2.60	0.42	1.04	3.54	0.83	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	139.18	13.49	3.07	0.51	1.02	2.56	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	105.01	9.63	5.42	4.32	1.88	2.55	0.77	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	130.04	17.47	4.08	2.25	2.08	1.33	1.66	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	125.78	14.29	4.08	0.82	1.23	1.23	0.61	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	87.06	9.28	3.30	2.68	1.44	2.89	2.48	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	106.76	12.45	5.88	3.80	3.34	1.96	2.31	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	96.39	12.01	8.00	2.33	2.67	2.00	2.50	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	74.06	10.36	4.19	2.65	2.42	1.32	1.98	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	99.62	11.44	5.41	2.46	2.95	2.46	2.46	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	110.71	10.70	6.48	5.02	3.40	3.40	1.30	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	121.87	11.87	5.45	4.17	4.81	2.89	1.60	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	75.42	5.97	4.64	2.46	1.71	1.80	2.08	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	95.22	12.81	3.95	2.21	1.42	0.95	2.53	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	123.46	14.90	6.39	3.95	2.74	3.04	1.82	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	87.60	9.62	5.96	4.70	2.51	2.09	1.05	1.88
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	74.21	10.10	4.17	1.54	1.32	2.42	2.20	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	93.98	9.82	5.61	3.37	3.37	3.93	1.96	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	93.88	9.44	3.98	1.57	2.13	1.76	0.56	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	93.32	9.36	3.48	1.87	1.87	0.27	1.60	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	100.98	12.85	4.90	4.13	4.13	1.84	1.38	2.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	62.83	6.74	2.59	1.42	2.20	1.17	0.91	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	79.15	11.66	1.90	1.08	0.54	1.36	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	93.10	8.85	6.08	3.13	4.06	2.21	1.66	2.40
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	105.05	7.90	5.48	4.39	1.32	3.51	2.19	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	147.77	21.82	7.93	0.99	4.96	1.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	74.13	6.60	2.90	1.45	2.24	2.51	2.37	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	73.04	7.06	3.63	1.82	3.03	2.62	2.82	2.42
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	169.78	20.59	3.30	0.51	2.29	2.54	0.25	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	250.22	29.26	8.16	2.99	3.38	3.38	1.00	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	140.83	15.56	13.71	4.78	6.32	4.16	3.85	3.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	203.76	22.91	11.46	5.32	3.27	3.27	2.86	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	104.21	7.20	0.00	0.31	0.00	0.63	1.25	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	81.09	9.89	1.13	0.28	0.00	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	261.04	18.91	19.83	5.07	10.15	7.84	7.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	94.04	22.27	7.42	9.90	7.42	4.95	14.85	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	131.51	15.09	7.35	5.80	4.64	3.09	2.32	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	118.73	4.81	4.81	8.02	1.60	6.42	8.02	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	128.67	15.65	20.87	13.91	5.22	12.17	6.96	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	118.15	11.07	5.86	5.53	3.25	5.86	1.95	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	153.60	11.94	10.30	6.59	3.29	5.35	2.88	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	149.95	19.99	43.32	16.66	23.33	29.99	13.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	128.92	13.98	5.59	4.47	1.96	4.75	3.08	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	121.91	13.07	5.23	6.54	4.25	6.86	3.92	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	139.25	15.94	15.94	26.00	17.62	4.19	13.42	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	136.45	15.59	6.36	4.77	1.91	6.36	1.59	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	130.09	9.51	5.43	3.74	2.72	3.74	2.04	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	119.02	4.18	12.53	2.09	6.26	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	143.75	18.90	4.58	5.15	1.72	5.73	5.15	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	100.34	11.54	4.44	5.92	3.26	3.26	4.14	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	116.90	13.55	18.64	11.86	6.78	3.39	13.55	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	140.00	18.23	5.38	6.63	5.80	4.14	6.63	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	135.32	15.42	7.13	3.91	3.45	4.60	3.45	2.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	10.54	10.54	15.81	10.54	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	113.79	8.84	4.23	5.38	1.92	5.00	5.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	104.64	10.76	2.61	3.59	2.61	2.93	0.65	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	66.22	10.70	1.34	0.67	0.00	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	114.81	11.17	6.16	8.86	5.01	6.55	2.31	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	193.42	15.75	14.38	11.64	8.22	7.53	5.48	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	151.57	22.36	12.42	27.33	12.42	9.94	14.91	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	133.06	15.10	7.55	8.49	4.72	7.08	2.83	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	107.42	10.86	4.83	3.02	1.21	7.24	6.03	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	107.84	9.16	2.54	0.51	2.54	2.54	2.03	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	129.22	11.17	8.77	4.79	3.19	4.39	5.58	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	123.34	10.85	11.35	4.93	3.95	3.45	3.95	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	167.62	24.79	7.08	3.54	7.08	7.08	11.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	93.93	8.75	5.25	6.42	0.58	6.42	2.92	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	115.86	14.48	4.83	5.71	1.76	3.51	4.83	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	99.18	18.65	9.32	4.24	4.24	5.93	4.24	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	67.45	5.97	4.78	5.97	1.19	2.98	3.58	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	75.21	7.28	5.82	1.94	0.00	4.37	4.37	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	50.22	5.71	0.00	2.28	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	51.98	6.24	2.08	2.49	2.08	2.91	4.57	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	23.61	3.37	0.00	0.00	0.00	0.00	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.99	7.29	2.54	2.85	0.95	1.90	2.54	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.98	2.51	0.00	0.42	0.42	0.42	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	76.36	12.18	4.06	1.74	2.55	3.02	3.13	2.44
Hep-2 cells mock treated, biol_rep2	11899-125E9	79.17	14.35	5.23	4.56	2.36	1.86	4.05	3.38
Hep-2 cells mock treated, biol_rep3	11900-125F1	92.82	13.65	8.42	5.46	3.41	1.82	4.10	5.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	74.22	11.91	4.04	5.25	2.62	3.94	3.61	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	74.79	13.54	3.22	1.93	1.50	2.58	1.50	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	82.45	21.53	5.81	3.88	2.58	1.94	1.94	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	64.39	8.84	3.99	3.61	1.74	2.62	3.61	3.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	64.50	10.29	4.12	3.09	0.86	1.72	1.37	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	68.56	11.21	3.52	3.84	2.24	1.60	2.56	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	44.77	2.80	0.56	0.00	0.56	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.34	1.30	0.00	0.43	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	7.93	7.93	7.93	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	23.99	3.53	0.00	0.71	0.35	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	30.51	2.91	1.45	1.45	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	33.74	3.67	1.57	1.22	0.17	1.57	2.10	0.87
Hepatocyte, donor1	11523-119I2	61.74	10.90	9.68	2.42	1.21	4.84	1.21	3.63
Hepatocyte, donor2	11603-120I1	76.49	9.70	5.39	0.00	2.15	3.23	1.08	1.08
Hepatocyte, donor3	11684-122I1	95.71	15.95	26.38	5.52	9.20	2.45	3.07	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	159.26	13.05	5.87	3.92	3.26	3.26	3.92	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	145.77	15.21	6.29	2.62	3.85	2.10	2.27	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	52.14	6.72	3.29	1.37	1.23	0.82	0.82	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	19.10	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	40.15	2.77	0.00	0.00	0.00	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	10.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	35.60	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	7.69	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	45.48	3.25	1.62	0.00	0.00	3.25	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	56.69	13.34	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	3.63	0.00	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	51.62	11.91	0.00	1.32	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	48.78	1.11	0.00	0.00	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.17	5.67	0.00	1.26	0.63	3.78	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	40.21	9.28	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	65.25	7.75	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	74.06	20.93	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	86.38	5.70	0.00	0.00	0.00	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	41.14	5.88	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	61.88	10.45	0.00	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	37.85	10.16	0.00	0.92	0.00	0.92	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	30.21	5.66	0.47	0.47	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	32.65	4.53	0.00	0.00	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	53.81	5.38	0.00	1.08	0.00	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	49.55	10.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	49.74	7.01	0.64	0.00	0.00	1.28	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	43.74	10.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	55.70	7.14	1.43	0.71	0.71	1.43	1.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	9.95	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	47.53	4.94	0.62	0.31	0.31	0.00	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	49.17	12.29	0.00	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	9.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	57.02	9.04	0.00	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	2.21	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	9.73	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	39.24	4.36	0.87	0.00	0.87	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	3.48	0.00	0.00	0.00	0.00	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	37.34	6.40	1.07	0.00	0.00	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	51.26	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	14.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	31.29	4.60	0.00	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	6.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	30.66	5.29	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	106.57	15.83	2.37	0.65	1.39	1.31	1.63	0.49
Keratinocyte - epidermal, donor2	11349-117G8	19.33	1.76	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	74.68	8.80	9.18	4.26	4.92	1.61	2.75	1.14
Keratinocyte - oral, donor1	11251-116E9	111.59	16.91	4.99	1.93	1.36	1.70	1.82	1.02
Keratocytes, donor1	11527-119I6	32.32	6.88	1.03	0.34	0.34	0.34	0.34	0.00
Keratocytes, donor2	11607-120I5	25.78	5.86	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	81.41	9.29	6.13	3.95	3.75	1.38	1.19	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	136.27	26.37	10.99	2.20	6.59	8.79	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	43.15	3.24	5.39	1.08	1.08	4.31	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	52.13	6.23	1.73	1.73	1.85	0.58	1.04	0.12
Lens Epithelial Cells, donor3	11690-122I7	71.44	9.08	1.51	0.71	0.20	0.40	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	55.02	8.06	0.36	0.47	0.59	0.36	1.07	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.88	4.19	2.51	0.84	0.56	0.28	0.28	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	53.68	7.40	6.14	2.36	2.68	2.68	3.46	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	34.95	7.53	2.69	2.15	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	34.67	4.10	4.41	1.58	0.63	2.84	1.58	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	26.41	3.02	2.48	1.19	0.97	0.65	0.43	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	40.63	4.10	2.87	1.23	1.23	2.46	0.41	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.19	2.78	1.52	0.76	0.51	0.51	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	32.09	3.52	4.50	3.10	2.11	0.70	1.97	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	40.74	7.52	3.16	0.79	0.40	1.19	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.68	3.49	3.10	0.78	0.78	0.97	1.16	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.96	1.67	0.19	0.19	0.56	0.37	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.80	3.83	2.44	1.39	0.70	1.74	1.74	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	23.14	3.10	0.95	1.67	0.95	0.72	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.53	3.71	2.61	1.65	1.65	0.96	1.51	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.65	5.54	4.93	1.54	2.46	2.16	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.96	3.74	0.94	0.31	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	36.60	3.11	0.73	0.73	1.10	0.55	0.91	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	27.97	3.62	2.30	0.66	1.32	0.66	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.69	1.17	1.46	0.29	0.29	0.00	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	23.90	1.74	1.74	0.75	1.74	0.25	1.74	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	27.16	8.73	3.39	0.48	1.45	1.45	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	27.47	4.04	1.35	0.54	1.08	0.00	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.33	4.24	2.42	1.51	2.12	0.61	1.82	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	30.07	3.11	3.11	0.00	1.04	2.07	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.31	1.26	3.56	2.09	2.09	1.05	1.05	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.47	2.26	1.95	1.20	1.35	0.75	0.45	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	39.21	6.88	1.38	1.38	0.00	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.89	1.88	2.07	0.19	0.75	0.56	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	20.99	1.80	1.48	0.74	1.27	0.64	1.59	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	39.74	6.30	3.39	3.88	2.91	0.48	2.91	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	24.15	1.98	0.66	0.00	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	25.40	2.73	1.73	0.99	0.74	0.62	1.36	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.83	7.03	1.48	4.07	2.96	1.48	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.74	2.22	1.98	0.25	0.25	0.00	0.74	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	19.80	1.37	1.79	1.51	0.82	0.69	0.55	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	41.49	4.18	2.25	1.29	1.29	1.61	1.61	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	33.17	3.96	3.04	1.52	1.52	0.91	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.81	3.92	3.50	2.24	2.38	0.42	1.96	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.60	4.98	2.84	2.13	1.42	1.07	1.78	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.12	0.48	0.97	0.97	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.83	2.18	0.78	0.47	0.31	0.31	0.93	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.86	3.58	1.43	2.86	0.00	0.36	0.72	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.35	3.59	0.33	0.00	0.65	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	17.89	1.88	1.65	0.24	0.24	0.47	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	58.41	7.55	1.73	0.99	0.74	0.74	1.73	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.32	1.54	1.28	0.77	0.77	1.02	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	35.21	3.88	2.09	1.49	1.79	0.30	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	11.33	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.92	6.90	0.00	0.77	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	31.17	7.42	0.74	0.74	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	36.81	7.19	0.85	0.00	0.42	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	29.54	3.52	0.70	0.00	0.70	1.41	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	26.15	3.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.10	6.18	2.06	2.06	0.00	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	20.22	4.76	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	29.41	3.39	0.23	0.68	0.00	0.23	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	48.57	6.98	2.33	2.62	0.87	4.36	3.49	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	55.82	8.10	4.05	0.00	0.45	4.05	2.25	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.14	4.61	0.14	0.54	0.68	0.41	0.00	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	33.89	3.08	2.57	1.03	1.03	0.00	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	49.40	11.29	1.76	2.82	1.76	1.76	1.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.32	7.33	0.00	2.00	1.33	0.67	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	51.45	13.24	0.51	1.02	1.02	1.02	2.55	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	49.36	7.47	1.60	0.80	1.87	3.47	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	62.92	12.09	2.46	2.83	0.76	1.51	3.40	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	41.11	4.29	0.00	0.61	0.00	1.23	1.84	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.11	6.52	0.00	0.82	0.00	1.63	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	72.26	11.04	3.33	3.12	1.04	3.33	1.67	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	59.98	9.25	2.52	3.92	1.40	3.08	5.32	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	27.82	3.09	2.06	0.00	0.00	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	63.29	10.16	2.03	3.19	1.16	4.94	4.64	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	52.61	10.76	1.49	2.09	0.00	0.90	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	52.01	6.09	1.11	1.11	1.11	1.66	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	45.25	8.48	0.71	1.77	1.77	1.06	1.41	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	44.99	7.74	0.74	0.74	0.74	1.48	2.95	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	6.91	1.15	1.15	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	29.93	7.29	2.30	0.00	0.00	0.77	0.38	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	40.76	5.10	1.13	0.00	0.00	0.00	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	39.38	2.46	0.82	0.00	0.00	1.64	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.28	4.52	1.36	0.00	1.36	2.26	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.03	5.75	1.44	0.72	0.00	0.72	3.59	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	31.37	8.96	1.49	0.75	0.00	1.49	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	38.27	4.46	0.37	2.23	0.37	1.49	1.49	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	38.77	8.18	1.29	2.58	0.43	0.86	3.02	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	34.25	8.56	0.00	1.71	1.71	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	41.65	4.66	1.33	0.67	0.33	3.33	1.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	34.99	6.03	0.60	2.41	0.00	1.21	3.02	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	30.57	2.84	0.00	0.00	0.00	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	42.28	4.81	1.03	1.03	0.00	2.75	1.72	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	36.50	3.76	1.61	1.61	0.00	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.69	4.71	0.00	0.00	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	48.89	7.04	1.11	1.11	0.37	0.00	2.22	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	1.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	5.29	0.00	1.06	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	47.62	6.40	2.40	0.40	0.40	1.60	2.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.07	5.09	0.00	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	36.03	2.30	0.00	0.00	0.00	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	33.54	3.95	0.99	0.99	0.00	0.49	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	2.82	0.00	0.00	0.00	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	35.20	5.03	0.00	0.00	0.00	0.00	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.05	6.76	0.00	1.35	0.45	0.45	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	39.59	3.44	0.00	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	37.41	4.90	1.34	0.45	0.45	0.45	2.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	41.45	5.47	1.56	2.35	0.00	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	38.26	6.60	0.00	1.32	0.00	0.00	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	34.25	6.75	0.00	0.00	0.52	1.04	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	50.32	6.56	0.44	0.00	0.44	1.31	3.06	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.20	5.03	2.80	0.56	0.56	2.80	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	49.02	6.18	0.44	1.32	0.88	1.32	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	43.97	10.41	1.54	1.16	1.16	0.00	1.16	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	48.10	5.57	2.03	0.00	0.51	0.00	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	37.49	6.25	0.96	0.00	0.48	0.48	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	42.94	9.54	1.19	1.19	0.40	1.59	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	44.96	6.08	0.61	1.82	0.00	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.96	3.46	2.08	0.00	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	39.90	7.22	0.00	1.14	0.00	1.90	1.90	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	43.90	8.78	1.55	0.52	0.00	1.55	2.58	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	34.47	4.23	2.42	0.60	0.00	2.42	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	48.49	8.56	1.58	1.58	0.63	2.54	1.90	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	31.99	6.93	1.07	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.05	9.77	0.57	0.57	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	39.08	5.14	0.51	1.03	2.06	1.03	2.57	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	41.03	6.37	1.41	1.41	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	43.70	9.65	0.00	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	39.94	7.49	1.25	0.83	1.25	0.42	1.25	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	39.15	4.70	1.57	0.78	0.00	2.35	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.99	2.09	0.00	0.00	0.00	1.25	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	33.92	5.58	0.93	0.00	0.00	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.77	2.01	0.00	0.00	0.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.56	5.88	0.53	0.00	0.00	1.07	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.16	3.64	0.00	1.62	0.00	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	35.79	8.26	0.00	0.00	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	40.90	2.67	0.89	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	35.33	6.84	0.57	0.00	0.00	1.14	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	30.68	6.90	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	45.96	7.11	0.55	0.55	1.09	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.84	4.01	0.45	0.00	0.45	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.56	3.38	0.00	0.00	0.00	0.26	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	47.08	3.98	0.00	0.66	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	14.55	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	91.85	12.76	1.82	0.46	0.23	1.37	0.00	0.91
Macrophage - monocyte derived, donor2	11313-117C8	61.66	15.41	1.28	0.55	0.92	0.37	0.18	1.10
Macrophage - monocyte derived, donor3	11389-118C3	78.26	10.09	4.06	1.57	1.70	1.57	1.70	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	28.68	5.31	0.53	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	98.24	13.63	4.12	2.38	0.95	1.43	1.58	2.06
Mallassez-derived cells, donor3	11930-125I4	83.95	13.76	2.22	1.67	1.11	0.42	0.83	1.53
Mammary Epithelial Cell, donor1	11273-116H4	113.00	10.76	8.97	4.28	3.09	2.39	3.39	3.19
Mammary Epithelial Cell, donor2	11350-117G9	85.71	13.03	6.37	4.05	3.19	1.74	1.45	1.74
Mammary Epithelial Cell, donor3	11422-118F9	24.94	2.99	1.00	0.75	1.25	0.00	1.25	0.00
Mast cell - stimulated, donor1	11487-119E2	796.58	82.71	8.14	2.03	2.03	14.24	0.68	0.00
Mast cell, donor1	11563-120D6	101.44	18.82	4.65	1.51	2.05	1.95	0.87	0.87
Mast cell, donor2	11565-120D8	231.20	36.85	7.13	1.19	5.05	4.16	0.59	0.30
Mast cell, donor3	11566-120D9	303.24	50.43	6.08	1.80	2.93	2.03	0.90	0.23
Mast cell, donor4	11567-120E1	220.90	38.83	4.25	0.89	3.19	2.30	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	161.68	28.39	5.32	3.44	2.99	1.44	1.33	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	136.58	19.26	3.50	5.25	0.00	1.75	1.17	2.33
Mast cell, expanded, donor5	11939-126A4	96.60	16.75	1.49	2.06	0.46	0.46	1.26	1.49
Mast cell, expanded, donor8	11941-126A6	133.06	23.60	2.01	1.17	0.67	0.84	0.84	0.33
Melanocyte - dark, donor1	11502-119F8	35.42	3.38	0.99	0.60	0.60	0.10	0.60	0.60
Melanocyte - dark, donor2	11582-120F7	55.72	6.58	1.73	0.69	0.00	2.42	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	72.30	13.04	1.52	1.52	0.94	0.87	1.16	1.01
Melanocyte - light, donor1	11274-116H5	23.51	4.23	1.65	0.94	1.18	0.47	0.24	0.24
Melanocyte - light, donor2	11351-117H1	14.33	2.73	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	10.41	2.60	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	56.64	6.66	1.87	1.46	0.83	0.94	0.52	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	53.52	7.26	2.96	1.88	1.61	1.61	0.81	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	91.07	14.20	2.14	0.27	1.61	2.14	1.87	0.27
Meningeal Cells, donor1	11493-119E8	76.54	10.79	0.50	0.12	0.25	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	57.66	8.80	1.32	0.00	0.00	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	92.18	10.60	1.39	1.14	0.49	1.96	1.96	1.06
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	46.48	3.71	1.14	0.57	0.57	0.57	2.28	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	70.44	11.57	1.71	0.10	0.81	0.70	0.30	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	3.94	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	14.39	3.92	1.31	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.82	6.46	5.74	5.02	2.15	1.44	3.59	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	52.52	10.59	2.12	1.06	1.48	2.12	0.64	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.76	6.53	3.52	0.50	1.51	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	35.16	6.15	0.88	0.22	0.88	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	35.80	2.92	0.73	1.46	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.96	5.52	0.41	0.00	0.00	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	47.37	8.59	1.80	1.80	0.42	0.69	0.83	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	25.65	2.97	0.74	0.37	0.00	0.37	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	68.68	8.55	3.42	1.05	1.84	1.84	1.97	1.97
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	30.86	3.56	1.48	0.89	0.00	0.30	0.00	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	0.00	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	4.48	1.92	0.00	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	40.05	8.51	2.84	1.42	0.71	1.42	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.03	5.63	1.25	0.31	1.25	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	28.30	2.18	0.00	1.45	0.00	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	53.30	7.42	2.65	1.33	1.33	0.27	0.53	2.12
Mesothelial Cells, donor2	12156-128G5	28.03	3.50	0.50	0.00	1.50	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	50.22	5.93	4.41	2.53	3.54	2.02	2.53	1.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	93.17	8.10	6.75	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	116.98	15.27	1.97	0.99	1.72	3.20	0.74	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	68.61	11.48	5.01	1.18	2.06	1.77	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	3.46	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	79.35	8.99	2.48	0.00	0.62	2.17	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	42.94	9.54	3.11	2.28	1.87	0.83	1.45	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	6.95	9.26	0.00	4.63	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	82.09	11.76	1.50	0.75	1.25	1.25	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	67.03	13.50	2.33	1.86	0.47	1.86	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	58.93	8.74	1.22	1.83	1.22	0.81	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	65.33	11.88	4.75	0.40	1.58	1.19	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	17.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	52.21	6.19	0.00	0.88	0.88	4.42	0.88	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	41.79	5.32	1.90	1.90	2.28	1.52	0.38	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	48.69	7.90	11.84	0.00	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	69.19	10.19	2.97	1.49	1.91	1.91	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	46.96	2.76	3.68	0.92	0.00	2.76	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	73.62	11.33	2.68	3.87	1.49	2.09	0.30	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	1.68	10.06	1.68	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	64.73	5.27	2.01	3.51	1.25	2.01	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	55.85	8.08	4.75	2.14	1.43	0.95	0.95	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	80.17	6.63	2.21	0.00	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	81.51	12.89	2.99	1.38	1.38	1.61	0.92	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	68.78	9.89	3.79	0.63	1.26	1.47	1.89	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	72.16	9.99	1.83	1.83	0.82	1.22	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	65.01	8.37	2.36	1.72	1.72	1.93	0.86	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	64.69	7.56	2.89	1.33	1.33	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	78.41	8.54	2.85	1.75	1.31	1.75	1.31	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	61.34	4.56	4.06	0.51	1.01	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	69.59	4.97	6.63	1.66	1.66	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	98.93	10.06	4.35	0.27	1.36	3.81	0.27	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	73.23	14.41	1.76	1.76	1.18	1.76	0.88	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	81.77	11.99	21.81	2.18	0.00	6.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	40.37	6.73	1.44	1.44	0.48	1.92	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	81.25	11.21	4.00	2.40	2.40	1.60	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	90.50	5.48	2.74	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	58.57	6.01	2.00	1.50	2.00	1.50	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	55.04	2.04	6.12	0.00	0.00	6.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	70.07	9.20	2.63	0.44	0.88	1.75	0.44	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	86.08	13.24	7.73	0.00	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	81.33	5.76	4.48	0.64	0.00	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	79.58	12.64	2.48	1.74	1.98	1.74	0.99	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	91.86	5.57	2.78	0.70	0.70	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	68.51	8.84	8.84	0.00	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	74.53	10.94	4.44	1.71	1.37	1.37	2.39	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	80.52	9.19	2.19	0.44	0.88	1.31	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	78.12	6.75	6.39	0.36	2.13	4.62	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	69.58	10.38	3.93	0.84	0.84	2.24	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	100.58	19.53	0.83	0.83	0.83	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	60.61	7.58	9.32	0.00	1.17	1.75	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	74.21	11.46	6.33	1.81	1.51	1.51	0.90	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	117.29	19.20	2.92	2.09	0.00	0.83	2.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	0.00	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	80.35	13.85	3.69	0.92	1.85	6.46	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	107.56	15.94	1.14	2.28	0.57	4.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	83.60	10.36	2.76	0.69	1.52	1.38	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	64.79	11.92	2.85	0.00	1.30	1.30	1.30	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	102.10	8.58	3.43	0.00	1.72	1.72	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	62.88	6.35	5.72	0.00	0.64	3.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	81.13	10.14	3.47	0.80	2.14	1.33	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	96.08	20.95	2.39	2.10	1.20	2.69	0.90	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	64.13	6.64	2.12	0.99	0.99	1.98	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	64.34	7.64	1.27	0.64	0.32	0.96	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	98.40	17.69	2.65	2.21	1.11	1.55	0.44	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	73.56	11.00	2.28	1.14	0.76	2.28	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	79.27	10.80	3.98	2.27	1.42	0.57	1.42	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	88.74	13.03	3.44	1.23	1.97	1.97	1.23	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	65.17	7.17	5.21	0.00	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	95.85	19.41	3.23	2.35	1.18	2.65	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	86.21	18.16	2.02	0.86	2.31	1.15	1.15	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	123.23	16.90	4.53	0.41	0.82	1.65	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	97.97	14.29	1.19	0.89	1.49	2.68	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	3.77	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	3.56	1.78	3.56	0.00	1.78	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	61.11	6.24	3.94	2.30	2.30	1.64	2.30	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	31.56	4.21	2.10	0.00	1.05	1.05	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	67.02	10.08	0.59	0.20	0.59	0.20	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	52.15	7.45	0.00	0.00	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	60.08	10.14	3.38	2.63	3.00	0.75	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	32.76	3.73	0.00	0.27	0.27	1.07	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	48.75	6.56	1.02	0.68	0.68	0.34	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	26.52	4.42	0.74	0.00	0.00	2.21	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	63.39	6.60	6.60	1.47	2.20	2.20	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	62.22	4.67	14.00	9.33	9.33	10.89	4.67	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	34.74	5.34	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	38.38	5.05	3.03	3.03	1.01	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.68	7.17	2.11	0.84	1.69	1.26	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	61.29	9.53	0.00	0.00	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	31.15	5.72	0.00	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	48.59	4.86	2.43	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	37.76	3.02	1.51	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	194.15	17.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	169.65	22.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	57.09	7.97	2.80	1.94	1.08	1.72	2.59	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	55.92	7.84	1.57	1.05	3.14	2.61	1.05	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	55.40	8.68	0.67	2.00	0.00	2.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	42.15	4.17	0.83	0.42	0.00	0.83	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	110.47	15.97	1.71	0.76	0.95	3.42	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	157.99	14.36	7.98	0.00	3.19	4.79	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	34.00	5.44	0.00	0.00	0.68	2.72	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	178.25	36.75	12.86	7.35	7.35	9.19	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	33.90	2.93	0.42	0.84	0.00	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	66.48	5.81	0.00	0.00	0.46	0.93	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	51.88	6.49	0.27	0.00	0.00	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	80.94	13.46	2.52	1.68	1.68	0.84	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	434.25	100.21	89.08	44.54	33.40	33.40	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	46.66	10.92	1.49	0.00	0.00	0.00	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	47.91	8.66	1.62	0.27	0.81	2.44	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	52.36	6.35	0.91	1.36	0.00	1.36	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	39.52	6.37	0.65	0.49	0.00	0.65	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	86.75	12.39	2.55	1.46	1.46	0.91	1.82	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	55.70	6.90	0.00	2.12	0.53	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	52.23	3.60	0.00	0.00	1.20	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	118.80	17.39	3.94	1.64	2.63	6.24	1.64	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	41.79	5.53	0.16	0.33	0.16	0.49	0.16	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	110.06	14.29	1.94	1.76	1.41	1.94	1.94	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	50.63	7.74	0.70	0.00	1.41	2.11	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	51.95	6.44	1.38	1.38	0.00	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	57.52	6.75	1.61	0.32	0.64	0.64	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	113.81	14.49	1.72	1.38	1.38	3.10	2.41	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	232.62	68.27	15.17	7.59	17.70	30.34	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	85.77	8.24	1.78	0.89	1.11	2.45	0.22	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	46.15	6.35	0.85	0.00	0.42	2.96	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	56.25	8.07	0.71	0.71	0.24	1.19	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	48.08	6.44	0.43	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	469.44	126.39	90.28	45.14	0.00	72.22	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	47.32	6.66	0.33	0.67	0.33	2.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	77.10	9.47	1.35	1.35	0.90	2.71	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.44	5.56	1.19	0.79	0.00	1.19	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	41.79	8.36	0.93	1.86	0.00	1.86	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	50.70	9.46	0.00	0.76	0.00	1.14	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	42.04	8.47	1.30	0.33	0.33	1.30	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.68	6.97	0.44	0.00	0.44	2.18	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	86.39	11.31	2.71	0.45	0.90	1.36	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	54.68	7.94	0.00	0.00	0.00	3.53	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	61.17	7.31	0.66	0.00	0.00	1.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	55.56	8.93	0.99	0.00	0.00	0.50	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	39.43	6.13	0.00	0.38	0.00	0.77	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	58.07	8.77	0.00	1.21	0.60	2.72	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	72.94	7.07	1.33	1.77	0.66	0.22	0.66	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	55.57	5.42	0.68	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	214.60	81.75	30.66	5.11	30.66	25.55	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	44.51	7.32	0.61	0.61	0.00	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	43.75	3.46	0.31	0.00	0.00	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.36	4.54	1.82	0.61	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	47.47	6.33	2.37	0.79	0.00	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	124.70	15.87	3.40	2.27	2.27	12.47	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	202.32	40.46	25.29	5.06	15.17	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	48.70	7.45	1.24	1.24	0.99	0.99	0.87	0.37
Myoblast, donor2	11322-117D8	76.72	9.78	4.22	1.53	1.34	1.92	3.64	0.96
Myoblast, donor3	11398-118D3	63.90	13.79	1.68	1.01	0.67	1.01	0.34	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	125.65	16.05	5.69	4.52	3.21	2.92	2.33	2.77
Natural Killer Cells, donor1	11230-116C6	421.61	39.36	23.06	12.61	9.84	5.23	3.38	6.77
Natural Killer Cells, donor2	11311-117C6	391.72	36.79	27.14	20.20	15.38	9.35	11.16	12.06
Natural Killer Cells, donor3	11387-118C1	403.26	33.13	37.92	23.19	17.30	5.89	7.73	8.83
Neural stem cells, donor1	11275-116H6	245.71	37.38	5.08	1.45	2.54	5.08	0.73	0.36
Neural stem cells, donor2	11352-117H2	269.59	42.36	3.85	1.93	1.93	5.78	0.00	0.00
Neurons, donor1	11494-119E9	79.65	14.79	2.28	2.28	0.00	9.10	4.55	0.00
Neurons, donor2	11574-120E8	57.02	9.47	3.30	0.88	1.32	0.88	0.22	1.10
Neurons, donor3	11655-122E8	106.06	11.51	6.58	4.93	0.82	4.93	3.29	0.82
Neutrophils, donor1	11233-116C9	334.08	51.97	24.13	7.42	7.42	12.06	2.78	6.50
Neutrophils, donor2	11314-117C9	220.31	31.89	26.09	17.39	17.39	23.19	23.19	14.49
Neutrophils, donor3	11390-118C4	516.77	70.86	9.16	1.83	6.11	1.22	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	74.33	9.62	2.14	1.78	0.83	0.95	1.78	1.78
Nucleus Pulposus Cell, donor2	11409-118E5	25.07	4.23	0.65	1.30	0.00	0.98	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	46.33	7.42	0.80	1.80	0.00	1.40	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	76.95	6.88	3.03	3.17	1.51	2.75	3.44	1.65
Olfactory epithelial cells, donor2	11934-125I8	78.02	11.43	4.20	3.62	1.74	3.91	9.12	1.74
Olfactory epithelial cells, donor3	11935-125I9	64.92	8.40	1.36	1.93	1.82	3.52	1.48	2.61
Olfactory epithelial cells, donor4	11936-126A1	90.00	12.76	5.55	2.43	1.95	2.73	1.17	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	69.81	8.43	1.81	1.20	0.60	1.81	2.41	1.81
Osteoblast - differentiated, donor1	11276-116H7	26.37	7.23	0.00	0.00	0.00	0.00	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	16.00	2.29	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	21.10	3.10	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	15.63	1.17	0.78	0.00	0.00	0.39	0.39	0.20
Osteoblast, donor2	11354-117H4	88.49	14.75	6.32	0.70	1.40	3.51	1.40	1.40
Osteoblast, donor3	11426-118G4	35.19	3.02	0.18	0.18	0.36	0.00	0.71	0.18
Pancreatic stromal cells, donor1	11249-116E7	85.58	14.57	4.63	1.94	2.11	1.43	2.70	1.68
Pericytes, donor1	11491-119E6	20.81	2.45	0.56	0.11	0.00	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	25.13	1.81	0.45	0.45	0.23	0.45	0.00	0.23
Pericytes, donor3	11652-122E5	20.75	2.24	1.02	0.00	0.00	0.41	0.20	0.20
Perineurial Cells, donor1	11499-119F5	58.43	8.48	2.26	1.36	0.90	0.57	1.13	0.90
Perineurial Cells, donor2	11579-120F4	73.33	8.10	1.75	1.47	0.55	0.37	0.46	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	397.15	55.46	13.71	5.42	9.24	6.06	1.59	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	295.06	30.12	8.33	2.69	3.43	4.16	6.12	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	253.65	28.08	7.12	2.33	4.14	6.99	1.68	1.55
Placental Epithelial Cells, donor1	11278-116H9	27.03	4.07	0.24	0.00	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	21.07	4.44	3.33	1.11	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	22.97	1.96	1.18	0.98	0.59	0.39	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.67	2.53	0.00	0.63	0.32	1.90	2.22	0.32
Preadipocyte - breast, donor1	11467-119B9	55.71	7.88	1.31	0.56	0.75	0.38	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	113.69	23.89	2.61	1.96	1.31	1.96	0.78	0.78
Preadipocyte - breast, donor2	11328-117E5	30.17	3.60	1.80	1.13	0.68	2.03	1.13	0.68
Preadipocyte - omental, donor1	11468-119C1	63.62	9.38	1.07	0.75	0.85	0.64	0.75	0.43
Preadipocyte - omental, donor2	11329-117E6	56.30	9.17	1.75	0.44	0.44	1.31	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	43.83	7.02	3.15	2.29	1.72	2.86	1.86	1.72
Preadipocyte - perirenal, donor1	11469-119C2	10.83	0.00	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	27.03	3.69	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	91.02	12.57	11.16	4.07	7.08	4.96	3.01	3.01
Preadipocyte - subcutaneous, donor3	11428-118G6	36.44	4.26	1.87	1.70	1.70	0.85	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	98.55	14.62	4.19	1.96	2.79	2.61	1.02	0.65
Preadipocyte - visceral, donor2	11357-117H7	92.50	10.58	7.82	3.68	4.14	6.44	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	65.20	8.67	1.46	1.15	1.04	1.78	1.15	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	122.64	13.43	5.43	5.58	4.37	2.56	2.87	2.41
Prostate Epithelial Cells, donor2	11331-117E8	47.67	5.55	2.98	1.90	1.35	3.66	1.62	1.08
Prostate Epithelial Cells, donor3	11404-118D9	65.65	10.96	8.21	4.84	3.86	3.43	3.67	1.84
Prostate Stromal Cells, donor1	11254-116F3	52.74	7.63	1.71	2.62	1.25	0.46	1.25	0.68
Prostate Stromal Cells, donor2	11332-117E9	66.52	8.96	4.30	2.69	2.87	4.30	2.87	2.15
Prostate Stromal Cells, donor3	11405-118E1	38.58	5.53	2.50	1.88	1.88	1.56	1.46	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.15	3.65	1.09	0.36	0.00	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	56.07	6.93	1.25	1.39	0.83	0.49	1.18	0.83
Renal Epithelial Cells, donor1	11517-119H5	23.84	5.07	0.51	0.51	0.00	0.51	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	28.45	4.98	0.00	0.71	0.00	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	75.27	8.79	2.54	1.91	1.48	1.06	0.85	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	24.51	2.72	0.00	0.00	0.00	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	43.93	4.85	0.81	0.40	0.13	0.81	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	96.57	13.99	6.88	5.33	4.88	5.33	2.66	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	29.94	5.99	1.33	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	29.05	2.86	1.10	0.66	0.66	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	23.20	3.76	0.00	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	15.81	1.94	0.55	0.00	0.83	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	43.75	5.91	2.42	2.68	0.00	0.27	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	27.41	2.11	0.84	0.42	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.12	2.51	1.74	0.19	0.19	0.19	0.58	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	46.93	3.63	2.85	0.78	1.56	0.78	1.04	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	29.85	3.13	1.99	0.57	0.28	0.57	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	0.00	2.06	1.03	1.03	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	59.97	6.52	1.25	1.25	0.00	0.50	0.75	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	138.71	19.91	6.01	1.60	2.94	0.94	2.00	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	139.37	15.19	2.68	4.47	0.89	5.36	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	318.66	33.02	45.13	24.22	23.12	13.21	15.41	12.66
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	432.72	40.60	22.62	10.44	12.18	5.80	1.74	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	188.02	23.92	4.16	2.60	1.43	2.73	0.65	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	124.83	12.91	7.75	4.27	4.17	2.68	3.18	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	149.46	17.62	8.70	3.23	3.01	2.23	0.89	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	171.80	21.58	9.18	4.71	4.71	5.46	3.47	2.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	128.78	12.82	7.11	5.59	3.73	3.85	3.96	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	197.39	20.80	26.35	9.25	11.79	6.01	3.93	7.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	133.76	17.39	4.93	3.97	1.78	2.74	0.82	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	141.89	19.97	8.17	7.56	4.84	3.03	3.18	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	115.40	16.84	2.87	0.72	0.90	1.25	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	121.36	15.35	5.59	3.59	2.73	4.59	2.01	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	108.07	13.84	5.37	3.43	1.93	2.68	2.68	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	138.29	16.37	11.95	4.65	8.19	3.10	1.33	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	155.04	17.21	3.82	2.87	0.96	4.21	0.38	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	128.84	15.19	5.12	2.89	2.14	2.61	1.02	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	201.62	27.06	14.28	5.26	6.01	6.20	3.19	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	148.63	17.12	4.11	2.12	1.46	4.51	0.93	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	136.86	15.09	11.78	6.04	5.74	3.11	3.31	3.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	149.52	19.86	19.48	6.87	9.93	6.30	2.48	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	126.02	17.73	3.20	2.56	1.71	2.56	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	142.40	16.26	7.85	6.17	3.36	3.36	4.77	6.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	170.21	17.09	17.60	6.49	7.86	3.25	2.73	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	137.11	13.86	2.37	2.01	0.91	3.83	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	118.59	15.08	11.53	5.40	4.78	4.05	3.43	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	135.39	14.37	14.10	4.16	6.31	2.69	2.82	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	132.32	16.28	4.25	2.83	2.59	4.48	1.65	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	132.74	14.68	9.33	4.96	3.97	3.77	3.97	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	159.48	18.24	13.10	4.68	6.31	2.10	3.04	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	125.66	15.76	2.70	1.45	1.66	2.49	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	161.26	15.48	5.97	3.54	2.88	3.98	4.65	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	150.61	18.17	9.61	3.34	4.18	1.67	1.67	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	125.16	15.88	4.71	3.77	1.35	2.42	1.08	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	155.65	19.41	6.30	2.72	2.04	2.38	1.19	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	174.86	19.47	25.83	10.22	13.69	6.17	3.66	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	160.42	20.63	5.85	5.50	3.61	5.33	2.24	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	128.25	17.01	7.41	3.15	2.47	3.02	1.10	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	174.18	23.97	14.28	6.57	7.72	4.76	5.42	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	142.14	18.75	4.09	2.56	2.56	5.11	0.34	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	123.84	18.35	12.72	6.81	8.29	1.92	3.70	5.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	164.73	19.46	6.93	3.20	4.80	2.13	1.33	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	135.22	13.83	4.01	1.80	1.66	2.90	0.55	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	92.38	11.19	11.67	4.29	2.86	1.19	4.05	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	214.84	21.56	8.87	3.43	4.84	5.24	1.41	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	96.15	11.49	3.39	1.98	1.88	3.20	1.22	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	137.65	15.72	21.66	8.73	14.67	3.14	6.29	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	135.69	17.83	10.28	1.81	4.53	1.81	1.51	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	91.30	10.04	2.57	1.84	1.22	4.28	0.98	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	315.99	34.20	6.84	2.18	1.46	3.35	1.75	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	144.81	10.95	5.48	3.65	3.04	0.61	1.22	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	88.31	8.44	1.81	1.21	0.60	2.41	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	117.39	13.80	9.95	4.98	4.98	4.07	2.49	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	140.18	13.78	8.69	5.39	4.79	2.10	3.29	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	104.97	10.74	4.25	1.77	1.06	1.18	0.83	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	126.79	12.81	2.56	1.28	1.71	1.71	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	180.29	14.42	3.61	3.00	4.81	3.61	1.20	0.00
Schwann Cells, donor1	11498-119F4	35.55	3.39	0.38	0.19	0.19	0.56	0.00	0.19
Schwann Cells, donor2	11578-120F3	44.23	3.40	0.00	6.80	0.00	6.80	0.00	6.80
Schwann Cells, donor3	11659-122F3	57.18	7.01	3.72	2.19	0.66	1.75	2.41	1.10
Sebocyte, donor1	11220-116B5	81.07	15.34	1.64	0.00	0.00	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	39.52	4.14	1.38	0.00	1.38	1.38	2.76	0.92
Sebocyte, donor3	11378-118B1	29.06	4.74	1.03	0.21	0.21	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	36.45	4.97	1.66	3.31	1.66	1.66	1.66	1.66
Sertoli Cells, donor2	11333-117F1	56.49	8.47	5.65	2.82	0.00	5.65	8.47	2.82
Skeletal Muscle Cells, donor1	11281-116I3	61.14	10.03	2.11	0.88	0.88	0.97	1.41	0.35
Skeletal Muscle Cells, donor2	11358-117H8	14.46	1.45	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	37.62	9.20	0.84	0.00	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	97.56	12.10	1.41	0.94	0.47	2.20	0.94	0.94
Skeletal Muscle Cells, donor5	11455-119A6	84.43	7.73	1.04	1.19	0.45	1.64	0.59	0.45
Skeletal Muscle Cells, donor6	11459-119B1	104.81	12.31	1.85	1.39	1.23	1.23	2.00	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	108.11	13.99	2.52	2.52	1.76	1.64	1.89	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	76.05	9.85	2.71	2.14	2.43	1.71	2.14	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	101.09	10.42	4.66	1.39	2.38	2.58	1.59	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	72.63	9.52	2.61	1.01	1.94	1.60	1.35	1.52
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	5.07	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	32.20	4.95	0.00	0.00	0.00	0.14	0.14	0.28
Skin - palm, donor1	10286-104F7	161.17	18.80	32.23	0.00	16.12	18.80	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	42.24	6.92	2.45	0.58	1.15	1.73	0.86	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	383.59	62.16	6.54	5.73	4.09	22.08	5.73	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	52.19	5.84	0.91	0.26	0.52	1.95	0.13	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	84.38	13.21	2.36	1.95	1.53	1.11	1.11	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	76.24	7.74	1.69	1.41	1.41	1.83	1.27	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	284.61	37.43	13.53	4.23	5.50	7.61	1.48	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	66.71	10.72	5.17	2.17	2.25	2.32	1.50	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.97	0.93	0.31	0.00	0.31	1.54	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	120.50	18.68	2.45	1.78	1.56	4.00	0.89	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.33	7.64	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.51	8.18	1.10	0.22	0.22	0.00	0.66	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.48	5.51	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	40.95	6.95	0.00	0.00	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	48.04	6.00	3.00	1.00	2.00	2.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	32.34	5.06	0.53	0.13	0.53	0.13	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	56.52	6.87	7.31	3.99	5.76	3.55	2.88	1.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.77	4.35	0.51	0.00	0.00	0.26	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	57.63	8.14	0.98	0.33	0.00	0.65	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	74.13	8.56	2.07	1.77	0.89	1.77	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	48.40	5.69	1.85	0.85	0.71	0.85	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.88	1.79	0.16	0.00	0.00	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	72.46	10.96	7.00	4.26	2.74	3.96	0.61	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.53	5.30	0.51	0.00	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	36.72	0.00	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	24.80	0.95	0.48	0.00	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	60.61	8.55	1.03	0.88	0.29	1.03	0.88	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	69.31	8.82	0.86	1.08	0.43	1.51	1.29	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	65.60	7.87	1.78	0.84	1.68	0.73	2.10	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	30.94	4.95	0.15	0.00	0.31	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	22.64	2.16	0.00	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	43.63	4.78	0.00	0.00	0.00	0.00	0.60	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	23.22	3.41	0.00	0.00	0.00	0.00	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	69.50	9.97	3.22	2.12	1.33	0.31	3.30	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	71.46	13.28	4.03	0.81	2.42	2.11	1.31	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	54.61	6.83	4.55	2.50	1.14	2.50	3.19	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	26.57	1.81	0.00	0.00	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	107.82	17.49	8.48	1.06	2.38	3.44	1.85	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	68.84	12.25	2.40	0.93	0.53	1.33	0.53	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	51.47	8.14	4.63	4.76	1.25	2.63	2.38	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	33.23	7.61	0.51	0.76	0.00	0.51	1.01	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	49.91	7.09	0.60	0.30	0.60	0.15	0.75	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	34.51	4.50	0.00	0.00	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	42.64	12.92	0.00	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	38.60	7.91	0.00	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	35.85	3.53	1.01	0.50	0.50	0.00	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	32.91	5.01	0.00	0.63	0.00	0.00	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.44	1.47	0.29	0.00	0.00	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	64.06	10.41	1.08	0.25	0.42	0.08	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	53.72	5.14	0.93	1.40	0.00	0.47	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	19.00	4.75	0.29	0.14	0.14	0.14	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	29.57	5.10	1.27	0.76	0.25	0.76	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	24.82	2.44	0.00	0.00	0.00	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	82.03	13.28	3.35	1.82	1.54	1.40	1.26	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.27	4.78	0.67	0.50	0.17	0.00	0.42	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.76	2.38	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.57	3.67	0.00	0.00	0.24	0.00	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	73.80	11.93	1.99	2.43	1.10	1.55	0.22	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.62	5.56	0.88	0.00	0.29	0.29	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	58.11	6.61	1.17	2.14	1.17	0.78	0.97	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	61.88	5.29	4.50	3.70	0.79	4.76	1.32	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	83.69	11.53	1.86	4.46	2.60	3.72	2.98	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	76.90	8.26	3.59	5.03	1.44	5.75	2.16	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	44.00	6.25	1.42	0.57	1.14	1.99	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	83.50	7.48	0.00	1.58	0.79	5.91	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	67.81	7.36	3.56	2.79	1.02	3.81	2.29	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	78.67	9.18	5.19	5.99	2.80	7.59	1.20	3.59
Smooth muscle cells - airway, control, donor3	11968-126D6	53.92	7.11	0.84	2.93	1.67	2.09	1.25	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	50.88	7.33	1.83	0.00	0.46	0.92	1.83	0.00
Synoviocyte, donor1	11291-117A4	70.36	7.41	3.37	1.51	3.03	2.19	1.35	0.50
Synoviocyte, donor2	11368-117I9	49.45	6.54	4.36	2.85	3.02	1.84	1.01	0.84
Synoviocyte, donor3	11440-118H9	52.05	8.71	4.02	1.56	3.35	2.90	1.56	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	45.74	3.22	0.36	0.00	0.00	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	3.96	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	35.89	3.01	0.23	0.00	0.00	0.46	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	52.19	8.10	0.50	0.43	0.65	0.22	0.57	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	31.31	3.87	0.39	0.00	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	26.92	1.15	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	135.94	21.28	7.14	2.09	3.81	1.72	1.60	0.86
Urethra, donor2	10319-105A4	136.68	28.77	35.97	3.60	10.79	48.56	0.00	0.00
Urothelial Cells, donor1	11520-119H8	14.61	1.86	0.27	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	17.22	2.00	0.80	0.00	0.40	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	24.98	4.58	0.69	0.23	0.69	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	70.88	7.36	2.23	0.89	0.89	0.67	2.45	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	214.44	37.37	8.90	0.00	1.78	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	197.29	37.17	4.29	1.43	4.29	0.00	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	133.48	24.64	6.16	1.37	6.16	2.74	2.05	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	181.12	29.61	4.82	0.34	2.07	1.38	1.72	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	170.82	23.24	1.74	2.91	1.74	1.74	2.32	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	195.75	21.87	3.12	0.00	0.00	2.08	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	192.74	44.97	7.34	0.92	0.92	0.92	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	118.68	21.00	8.22	2.74	7.30	2.74	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	126.69	21.34	4.32	1.73	2.96	3.21	1.60	2.10
Wilms' tumor cell line:HFWT	10597-108E3	93.28	7.04	18.48	1.76	5.28	5.28	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	114.24	7.54	5.59	4.47	1.96	1.12	1.96	1.68
achilles tendon, donor2	10292-104G4	132.26	22.73	24.80	6.20	12.40	14.47	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	274.08	26.52	32.89	17.59	24.73	10.96	10.45	8.16
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	182.49	20.66	8.36	4.64	3.95	1.63	1.39	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	219.25	22.91	14.60	4.63	9.14	3.09	3.56	2.97
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	195.65	21.50	20.95	12.79	17.96	9.80	6.26	5.44
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	279.40	31.20	21.92	18.55	12.09	6.75	9.84	10.96
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	101.93	9.31	2.75	1.48	1.90	0.63	0.63	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	148.36	28.58	13.07	5.99	7.08	3.27	2.99	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	133.51	29.52	8.37	6.61	7.05	2.64	4.41	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	147.01	18.38	19.19	9.39	7.76	4.90	5.31	6.53
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	155.71	26.79	12.43	2.72	4.66	5.05	2.72	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	142.78	23.18	11.78	6.26	5.34	3.13	4.05	5.34
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	179.42	19.50	35.10	3.90	31.20	3.90	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	181.72	18.59	16.50	11.62	9.30	2.56	3.02	4.65
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	203.76	31.07	9.58	7.51	6.21	5.70	5.44	5.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	173.30	21.04	21.04	16.07	10.52	4.97	10.23	9.94
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	135.71	18.59	9.30	2.79	3.25	2.79	0.00	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	125.84	21.80	9.05	1.65	2.88	8.23	1.23	3.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	149.79	22.71	9.52	1.53	2.15	7.06	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	199.27	32.00	7.25	4.69	5.97	2.56	2.13	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	191.98	24.87	8.49	2.43	1.82	2.43	1.52	2.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	233.00	38.03	12.04	3.37	6.02	2.65	2.65	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	225.63	33.19	20.05	10.91	6.68	6.46	5.57	4.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	146.43	20.01	5.34	3.00	2.00	3.34	1.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	139.37	7.43	35.31	1.86	3.72	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	119.78	16.57	12.81	7.16	4.14	1.51	1.88	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	211.96	22.68	10.90	3.49	5.23	4.80	0.87	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	112.47	11.25	20.62	0.00	1.87	7.50	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	108.57	18.84	4.00	1.65	1.41	0.94	0.94	0.24
adipose tissue, adult, pool1	10010-101C1	132.94	24.35	5.89	1.24	2.17	2.48	1.40	1.71
adipose, donor1	10184-103D4	359.47	42.81	21.70	15.83	7.62	9.38	7.62	7.62
adipose, donor2	10185-103D5	90.43	13.79	3.24	2.43	1.22	2.03	0.41	2.03
adipose, donor3	10186-103D6	100.20	20.15	3.81	3.27	4.08	2.18	3.00	2.45
adipose, donor4	10187-103D7	138.68	41.60	13.87	10.40	6.07	7.80	9.53	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	126.89	16.10	4.58	1.74	2.53	1.74	0.79	0.63
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	95.65	16.68	4.14	2.40	1.73	0.67	1.47	1.33
alveolar cell carcinoma cell line:SW 1573	10708-109H6	142.92	24.30	6.79	2.50	3.93	3.93	3.22	2.50
amniotic membrane cells, donor1	12235-129G3	75.35	12.06	0.46	1.16	1.16	1.16	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	58.83	9.47	2.03	0.34	0.34	0.68	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	83.37	17.38	2.65	0.88	4.42	3.54	0.00	1.47
amygdala - adult, donor10196	10167-103B5	181.43	43.87	16.60	4.74	5.93	3.56	2.37	1.19
amygdala, adult, donor10252	10151-102I7	172.15	36.90	30.21	5.47	11.56	12.98	4.26	2.23
amygdala, newborn, donor10223	10360-105E9	125.23	20.01	5.49	1.94	3.87	7.75	0.97	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	55.52	8.02	2.93	1.40	1.66	1.27	0.76	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	201.65	32.87	11.47	9.93	8.60	6.62	5.74	4.85
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	170.69	9.69	17.37	5.01	9.35	3.01	2.00	1.00
aorta, adult, pool1	10052-101G7	102.97	18.63	4.71	2.75	1.96	3.14	1.57	0.20
appendix, adult	10189-103D9	244.51	27.94	8.93	2.33	3.88	3.49	1.94	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	141.01	23.73	7.57	2.41	4.82	4.13	2.41	3.78
artery, adult	10190-103E1	80.16	16.30	8.15	1.36	2.72	1.36	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	96.92	12.02	3.19	1.59	1.30	1.74	1.59	1.74
b cell line:RPMI1788	10427-106D4	166.55	26.02	11.15	5.06	4.46	3.27	3.87	2.53
basal cell carcinoma cell line:TE 354.T	10702-109G9	59.10	8.05	1.66	2.77	1.94	0.55	0.55	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	133.47	19.05	4.86	1.79	1.98	0.69	0.99	1.79
bile duct carcinoma cell line:TFK-1	10496-107C1	157.67	19.25	7.53	4.02	4.02	2.01	3.35	2.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	92.27	13.42	5.03	3.91	2.24	0.56	0.56	0.56
bladder, adult, pool1	10011-101C2	153.62	18.79	9.45	1.96	3.80	0.98	0.76	0.98
blood, adult, pool1	10053-101G8	97.44	13.29	0.00	0.00	4.43	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	125.03	12.85	4.28	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	134.29	17.55	34.42	8.77	17.55	21.59	11.47	7.42
brain, adult, donor1	10084-102B3	67.65	8.20	0.00	0.00	1.03	0.00	1.03	1.03
brain, adult, pool1	10012-101C3	108.35	24.94	7.68	2.34	2.67	2.90	1.56	1.56
brain, fetal, pool1	10085-102B4	98.84	10.69	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	184.01	20.48	18.17	2.97	6.28	10.57	4.96	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	258.26	34.58	8.24	3.00	3.12	1.37	1.50	0.62
breast, adult, donor1	10080-102A8	99.75	8.84	2.53	0.00	1.26	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	134.66	21.47	8.77	3.94	3.18	3.68	2.29	2.92
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	188.62	21.34	10.51	2.47	3.71	3.09	1.86	4.33
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	109.58	18.42	3.68	2.53	1.38	4.37	1.84	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	184.23	30.74	9.68	4.84	3.87	3.39	4.60	3.87
carcinoid cell line:NCI-H1770	10703-109H1	192.30	29.15	10.81	5.64	3.76	9.87	0.47	1.88
carcinoid cell line:NCI-H727	10735-110B6	144.05	14.55	7.77	2.19	2.73	1.97	0.55	1.64
carcinoid cell line:SK-PN-DW	10719-109I8	130.56	16.80	7.61	3.49	5.07	3.80	2.54	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	204.96	30.88	14.91	9.85	8.52	7.99	6.92	6.39
caudate nucleus - adult, donor10196	10177-103C6	171.55	43.75	9.21	2.30	3.45	3.45	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	142.56	30.45	21.92	6.69	7.20	3.68	4.35	2.68
caudate nucleus, adult, donor10258	10379-105H1	119.21	33.62	9.93	6.11	3.82	1.53	0.76	4.58
caudate nucleus, newborn, donor10223	10354-105E3	176.16	18.31	2.20	0.37	2.93	6.59	1.10	0.37
cerebellum - adult, donor10196	10173-103C2	320.46	90.31	23.31	2.91	8.74	8.74	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	317.28	68.96	39.71	11.53	15.80	14.52	8.11	6.19
cerebellum, adult, pool1	10083-102B2	109.69	23.11	6.21	2.07	2.41	3.45	3.10	1.38
cerebellum, newborn, donor10223	10357-105E6	239.95	35.70	25.74	9.96	10.79	14.95	4.98	3.32
cerebral meninges, adult	10188-103D8	75.64	16.89	8.32	1.01	2.52	1.76	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	68.70	11.69	12.43	2.19	8.04	6.58	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	94.18	18.84	2.16	1.73	1.73	1.58	0.86	0.58
cervical cancer cell line:ME-180	10553-107I4	79.71	10.77	1.99	0.83	0.50	1.66	0.99	1.33
cervix, adult, pool1	10013-101C4	188.77	34.23	11.55	3.36	4.51	4.20	1.57	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	65.35	9.61	0.84	0.98	0.42	0.84	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	47.03	7.84	3.92	0.00	1.31	6.53	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	163.55	23.36	7.83	4.47	4.60	4.35	3.85	1.49
choriocarcinoma cell line:SCH	10785-110H2	132.45	15.40	6.04	4.07	3.94	3.33	3.33	2.71
choriocarcinoma cell line:T3M-3	10618-108G6	195.20	21.35	5.46	1.90	4.03	3.32	0.95	1.19
chorionic membrane cells, donor1	12238-129G6	64.39	7.69	1.99	0.57	1.14	1.14	2.56	1.14
chorionic membrane cells, donor2	12239-129G7	76.06	9.45	1.59	0.99	0.80	0.99	0.50	0.50
chorionic membrane cells, donor3	12240-129G8	92.31	12.64	6.59	4.95	3.30	4.40	4.40	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	80.78	10.10	5.05	2.02	3.03	5.05	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	153.49	28.81	6.15	2.88	3.46	3.65	0.77	1.73
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	163.46	20.06	4.43	1.48	1.90	2.53	1.48	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	180.53	28.76	5.14	3.60	4.11	5.39	3.08	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	219.38	26.12	8.22	2.90	2.66	6.53	3.63	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	218.47	26.27	10.99	3.66	5.09	6.31	3.05	2.85
chronic myelogenous leukemia cell line:K562	10454-106G4	261.77	40.05	15.02	6.48	5.89	5.01	2.36	2.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	289.82	26.84	8.60	4.43	5.99	2.87	1.82	2.35
clear cell carcinoma cell line:JHOC-5	10638-108I8	178.29	20.57	11.66	8.23	4.80	10.06	8.23	3.89
clear cell carcinoma cell line:TEN	10636-108I6	139.85	17.35	5.21	2.26	3.12	1.21	1.04	0.87
colon carcinoma cell line:CACO-2	10513-107D9	164.37	19.95	4.58	2.38	1.46	1.65	1.65	1.28
colon carcinoma cell line:COLO-320	10420-106C6	221.59	30.79	7.98	3.80	6.08	2.66	1.52	1.52
colon, adult, donor1	10082-102B1	96.39	8.33	3.57	0.00	0.00	7.14	0.00	0.00
colon, adult, pool1	10014-101C5	134.07	21.39	6.82	1.06	2.70	1.65	0.71	0.47
colon, fetal, donor1	10070-101I7	160.06	15.45	5.56	0.62	4.94	1.24	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	513.35	82.50	4.58	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	365.02	87.96	10.20	2.55	5.52	7.65	1.27	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	189.87	29.88	4.68	0.91	1.96	1.81	1.06	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	231.40	41.74	7.76	3.95	3.24	1.55	1.55	1.69
corpus callosum, adult, pool1	10042-101F6	118.41	28.75	5.86	1.88	2.99	1.66	1.11	1.00
cruciate ligament, donor2	10295-104G7	129.68	23.50	27.56	5.67	12.16	13.78	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	108.35	10.43	2.41	0.80	1.61	3.21	2.41	0.80
diencephalon, adult	10193-103E4	79.68	19.44	7.68	3.12	2.40	1.20	1.44	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	267.04	24.11	24.80	16.07	10.56	4.82	17.45	7.81
ductal cell carcinoma cell line:KLM-1	10438-106E6	217.72	20.26	6.92	2.82	1.80	1.03	1.03	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	88.34	9.87	8.67	3.61	5.78	1.69	4.09	1.44
ductus deferens, adult	10196-103E7	191.36	33.39	14.45	4.49	3.49	5.98	1.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	149.78	15.84	11.52	0.00	2.88	11.52	4.32	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	196.42	30.90	27.22	13.24	9.56	6.62	9.56	4.41
dura mater, adult, donor1	10041-101F5	164.84	27.67	6.61	2.81	3.39	0.99	1.16	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	148.34	17.10	3.33	0.89	0.89	2.44	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	139.28	16.91	4.73	1.72	2.15	1.86	1.00	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	128.26	10.48	8.63	1.23	6.17	4.32	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	94.45	16.04	3.03	0.61	0.00	1.82	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	133.38	17.29	6.17	0.93	1.54	2.47	1.23	0.93
embryonic pancreas cell line:2C6	10603-108E9	152.36	18.39	3.94	0.00	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	274.86	29.83	13.41	3.02	7.71	5.03	0.67	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	103.85	17.04	9.79	9.79	7.61	5.62	3.26	2.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	74.13	6.75	4.18	2.89	2.89	1.77	2.41	0.96
epidermoid carcinoma cell line:A431	10426-106D3	231.32	22.79	10.78	2.45	5.00	2.45	0.67	2.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	138.25	12.10	6.27	2.31	4.84	1.76	1.65	1.98
epididymis, adult	10197-103E8	149.24	22.19	10.26	3.14	2.09	2.30	2.30	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	88.35	15.61	10.82	5.50	4.97	2.66	1.95	2.66
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	82.19	9.83	3.93	3.15	1.97	0.39	0.00	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	154.25	23.85	5.77	3.54	2.88	6.16	5.11	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	169.18	24.70	8.07	2.95	3.44	4.82	4.13	2.07
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	131.07	20.61	6.50	3.36	3.70	5.60	4.15	2.13
esophagus, adult, pool1	10015-101C6	120.30	16.78	5.20	1.49	1.81	1.49	1.17	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	236.20	35.44	6.64	2.88	1.63	1.88	1.88	1.63
eye - muscle inferior rectus, donor1	10272-104E2	113.48	12.07	45.88	0.00	12.07	28.97	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	90.48	16.83	18.94	0.00	6.31	10.52	2.10	0.00
eye - muscle medial, donor2	10299-104H2	78.88	10.42	23.81	1.49	10.42	11.91	0.00	0.00
eye - muscle superior, donor2	10297-104G9	99.75	21.78	24.08	5.73	8.03	9.17	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	77.24	16.03	18.95	2.91	5.83	4.37	0.00	1.46
eye, fetal, donor1	10054-101G9	98.64	18.81	7.37	2.54	4.32	2.29	2.80	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	83.09	11.41	5.39	2.95	2.05	1.03	1.15	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	76.69	13.53	4.04	2.14	2.14	0.71	1.90	0.24
frontal lobe, adult, pool1	10040-101F4	134.92	41.00	8.63	2.63	2.91	1.97	1.41	1.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	196.36	28.22	32.73	12.01	17.71	8.71	6.00	5.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	174.09	27.89	3.66	2.10	2.29	1.37	0.64	1.01
gall bladder, adult	10198-103E9	107.44	15.93	6.52	0.24	1.45	1.45	1.69	0.72
gamma delta positive T cells, donor1	11937-126A2	227.63	27.92	1.61	2.68	1.61	2.15	2.68	1.07
gamma delta positive T cells, donor2	11938-126A3	198.32	19.42	1.87	1.87	2.61	0.75	1.49	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	109.41	10.56	6.55	6.55	3.59	2.53	6.34	3.80
gastric adenocarcinoma cell line:MKN45	10612-108F9	112.76	13.93	5.42	5.42	3.29	3.29	2.32	4.26
gastric cancer cell line:AZ521	10549-107H9	84.93	12.13	1.80	1.31	0.66	2.30	0.98	0.49
gastric cancer cell line:GSS	10560-108A2	95.18	20.13	4.58	3.66	2.75	0.92	2.75	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	179.80	12.57	17.13	7.77	5.25	4.34	6.17	6.63
giant cell carcinoma cell line:LU65	10487-107B1	100.63	17.21	5.74	2.41	1.95	2.29	2.75	1.95
giant cell carcinoma cell line:Lu99B	10433-106E1	144.86	32.33	5.46	1.68	3.50	2.38	1.54	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	99.27	14.22	5.99	3.49	2.00	3.99	2.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	180.71	31.24	9.71	4.01	5.07	4.33	1.37	2.22
glioblastoma cell line:A172, tech_rep2	10444-106F3	180.04	33.42	17.55	5.48	7.02	2.67	1.54	3.23
glioblastoma cell line:T98G	10485-107A8	124.83	18.21	6.62	2.87	2.43	3.64	1.77	2.21
glioma cell line:GI-1	10413-106B8	178.66	20.50	6.44	0.59	2.93	1.17	2.93	1.17
globus pallidus - adult, donor10196	10175-103C4	137.76	26.24	6.56	3.64	2.19	3.64	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	229.45	43.20	28.31	10.25	14.65	6.83	4.88	2.44
globus pallidus, adult, donor10258	10367-105F7	67.09	17.80	2.74	5.48	2.74	8.22	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	91.66	10.66	1.60	0.53	0.53	2.13	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	440.49	88.10	4.89	0.00	0.00	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	32.79	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	90.24	9.28	2.56	1.92	1.28	2.56	2.56	0.64
hIPS +CCl2, biol_rep1	14383-156B9	173.55	24.33	5.05	4.59	4.13	6.89	2.30	2.75
hIPS +CCl2, biol_rep2	14384-156C1	164.16	24.69	7.32	3.66	0.46	4.12	3.20	2.74
hIPS +CCl2, biol_rep3	14385-156C2	132.68	18.68	4.51	2.58	0.64	6.44	4.51	0.64
hIPS, biol_rep1	14380-156B6	76.18	17.25	2.87	5.75	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	123.46	13.03	2.74	4.80	0.69	6.17	2.06	3.43
hIPS, biol_rep3	14382-156B8	121.38	34.21	15.45	3.31	4.41	7.72	2.21	3.31
hairy cell leukemia cell line:Mo	10712-109I1	135.05	20.69	9.48	6.32	5.46	5.75	2.59	4.60
heart - mitral valve, adult	10205-103F7	119.89	20.63	6.58	1.20	2.99	1.79	1.20	1.20
heart - pulmonic valve, adult	10206-103F8	138.32	23.01	24.06	4.18	10.20	13.07	2.09	1.31
heart - tricuspid valve, adult	10207-103F9	195.67	16.65	44.96	2.50	19.98	3.33	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	63.05	7.35	3.67	2.86	3.06	3.06	2.45	1.84
heart, adult, diseased, donor1	10051-101G6	41.73	10.22	0.85	0.43	0.43	1.70	2.55	0.00
heart, adult, pool1	10016-101C7	82.10	11.27	2.30	0.00	0.69	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	136.36	20.43	6.06	1.33	3.18	1.33	0.82	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	72.50	10.80	4.32	0.00	0.62	1.23	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	164.11	11.89	29.73	1.19	4.76	9.51	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	172.15	18.23	8.95	3.43	5.30	4.31	3.76	1.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	175.39	16.39	7.40	3.28	4.61	6.43	2.79	1.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	188.36	20.31	7.88	4.14	4.04	6.57	2.12	3.33
hepatoma cell line:Li-7	10484-107A7	106.77	11.01	6.45	3.78	2.89	2.67	1.89	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	111.76	11.86	4.62	2.51	2.61	2.91	1.81	1.31
hippocampus - adult, donor10196	10169-103B7	137.22	23.66	26.50	12.30	8.52	2.84	2.84	1.89
hippocampus, adult, donor10252	10153-102I9	167.36	31.02	27.96	8.98	12.45	11.02	5.31	1.43
hippocampus, adult, donor10258	10374-105G5	100.09	29.38	14.94	11.45	4.98	2.99	1.49	3.98
hippocampus, newborn, donor10223	10363-105F3	83.18	10.22	3.17	2.11	0.70	1.76	1.06	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	306.39	29.30	6.71	4.88	2.44	8.54	10.38	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	140.98	11.98	7.66	8.84	2.95	5.69	2.16	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	180.27	14.47	3.30	5.59	2.03	6.09	2.29	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	118.98	15.79	0.56	1.13	1.13	3.95	3.38	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	163.19	15.49	6.71	4.39	2.84	6.20	20.40	5.16
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	143.11	10.63	4.56	3.42	2.28	3.80	2.28	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	162.91	17.23	4.38	2.63	2.63	4.38	2.92	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	158.99	20.68	4.74	9.91	2.37	1.94	4.09	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	130.54	11.68	3.75	2.09	0.83	2.09	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	98.74	12.55	1.66	1.66	1.42	1.66	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	143.68	16.39	3.54	6.11	3.21	4.02	3.38	3.70
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	100.32	11.45	1.35	0.67	0.00	0.67	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	152.73	12.83	7.20	4.85	3.60	5.01	3.91	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	191.11	18.18	8.35	5.90	4.42	4.91	13.26	7.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	271.43	26.18	5.24	5.24	2.62	13.96	5.24	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	180.22	21.00	4.77	4.20	2.10	4.01	2.86	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	158.29	22.24	5.67	4.36	3.92	3.92	2.18	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	234.39	22.49	4.00	2.50	1.00	4.50	6.50	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	134.70	17.71	6.22	2.83	2.64	2.45	2.07	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	119.59	19.10	3.64	3.18	1.82	2.27	1.36	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	119.66	11.90	3.76	4.70	0.63	2.51	1.57	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	107.13	13.39	6.04	4.41	2.45	2.29	2.78	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	89.12	10.16	4.35	4.06	1.74	2.90	1.74	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	103.13	13.75	2.09	3.59	2.09	3.59	4.48	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	142.07	12.01	6.65	8.87	2.03	4.99	4.62	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	136.37	12.55	3.99	3.99	2.57	4.85	3.71	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	211.51	21.64	5.72	3.27	2.86	5.72	6.53	4.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	153.16	15.49	5.99	7.75	1.76	2.46	9.15	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	121.95	15.20	4.43	3.48	2.53	3.17	2.53	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	119.54	12.71	5.14	1.21	1.82	2.72	3.63	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	112.22	18.10	3.10	2.07	2.59	1.03	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	106.27	20.59	3.98	2.66	0.66	0.66	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	72.34	7.95	3.59	2.05	1.03	1.28	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	101.49	12.78	4.09	2.56	2.56	2.05	2.56	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	118.88	13.63	5.30	0.00	2.27	0.76	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	97.12	10.75	1.68	2.02	1.34	3.36	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	166.64	12.56	4.83	6.28	2.90	6.28	3.62	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	188.96	15.60	7.58	4.90	2.23	7.13	4.46	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	160.49	15.61	2.93	4.39	2.44	8.78	5.85	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	138.75	15.89	6.42	5.81	1.83	4.89	1.83	2.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1086.58	152.90	32.53	16.27	9.76	22.77	68.32	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	214.45	18.86	2.65	3.97	1.99	5.63	4.63	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	126.97	21.89	4.38	2.19	1.09	1.64	1.64	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	104.95	9.77	3.26	3.62	0.72	2.90	1.81	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	105.34	16.37	2.85	2.85	0.00	3.20	1.07	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	114.56	21.48	3.58	2.39	0.00	4.77	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	148.16	17.61	2.30	2.44	1.90	0.54	1.49	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	87.01	6.73	2.42	0.54	1.62	4.58	1.62	1.08
immature langerhans cells, donor1	11904-125F5	324.23	28.82	7.02	2.91	3.39	2.18	3.15	1.70
immature langerhans cells, donor2	11905-125F6	141.00	7.92	0.79	1.58	0.79	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	100.31	26.12	3.41	1.14	1.80	1.51	0.66	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	78.69	8.45	3.25	0.33	1.63	3.90	0.65	0.65
kidney, adult, pool1	10017-101C8	115.85	17.52	7.81	1.60	3.60	1.60	2.00	1.10
kidney, fetal, pool1	10045-101F9	111.90	17.19	1.41	0.64	0.64	0.57	0.42	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	201.53	28.69	3.55	1.14	1.85	1.14	0.43	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	65.94	6.22	2.07	2.49	1.52	3.18	2.21	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	104.23	14.68	2.20	0.92	1.28	1.47	0.55	0.55
left atrium, adult, donor1	10079-102A7	77.91	4.90	3.81	0.54	3.81	1.63	1.09	0.54
left ventricle, adult, donor1	10078-102A6	54.61	4.05	2.53	0.00	2.02	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	128.87	14.50	3.28	1.64	2.74	2.19	0.00	1.09
leiomyoma cell line:10964C	10569-108B2	32.69	5.75	0.72	1.08	1.80	0.36	1.80	0.72
leiomyoma cell line:15242A	10570-108B3	17.39	2.72	1.63	1.63	0.54	0.00	0.54	1.09
leiomyoma cell line:15425	10571-108B4	40.06	7.77	0.49	1.46	0.73	2.19	2.91	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	12.70	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	103.51	28.23	1.05	1.05	0.00	5.23	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	159.14	11.57	8.74	4.25	3.07	2.48	2.83	2.01
liposarcoma cell line:KMLS-1	10782-110G8	102.79	11.56	3.28	2.19	3.44	3.12	0.62	0.31
liposarcoma cell line:SW 872	10726-110A6	85.90	6.94	3.53	0.97	1.83	1.83	0.37	0.85
liver, adult, pool1	10018-101C9	65.80	10.21	2.59	0.32	1.78	1.13	0.97	0.97
liver, fetal, pool1	10086-102B5	57.38	2.82	0.00	0.94	0.00	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	168.57	33.10	30.48	4.52	9.92	5.69	2.19	1.75
locus coeruleus, adult, donor10252	10165-103B3	148.93	29.16	22.88	4.06	10.33	5.54	3.88	1.29
locus coeruleus, adult, donor10258	10375-105G6	99.59	20.88	5.36	1.97	1.97	3.67	3.10	1.13
locus coeruleus, newborn, donor10223	10362-105F2	211.15	25.24	13.04	2.94	7.99	7.99	2.10	1.68
lung adenocarcinoma cell line:A549	10499-107C4	78.05	8.30	2.08	0.83	1.11	0.69	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	111.68	24.82	2.76	0.00	0.00	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	151.98	17.53	5.40	2.37	2.11	3.43	0.53	0.40
lung, adult, pool1	10019-101D1	119.90	20.79	7.09	0.83	2.48	1.18	0.71	0.35
lung, fetal, donor1	10068-101I5	481.77	83.62	16.27	3.42	3.71	5.42	1.43	1.43
lung, right lower lobe, adult, donor1	10075-102A3	134.72	24.29	6.42	3.21	4.12	4.58	6.42	2.29
lymph node, adult, donor1	10077-102A5	131.12	12.78	8.05	3.79	5.21	2.37	6.15	1.42
lymphangiectasia cell line:DS-1	10727-110A7	257.97	32.88	8.99	3.73	4.16	4.60	2.85	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	177.04	26.56	6.64	2.41	3.17	2.11	2.72	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	257.40	13.59	6.80	4.25	2.55	1.70	0.00	1.70
mature adipocyte, donor1	12231-129F8	69.26	11.99	1.78	0.00	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	87.58	19.72	1.04	0.62	0.83	0.62	0.62	0.00
mature adipocyte, donor3	12233-129G1	87.24	14.70	0.24	0.00	0.47	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	100.02	18.95	0.79	0.26	0.26	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	261.13	48.37	6.67	1.91	2.62	1.43	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	159.05	34.97	12.41	0.00	10.15	1.13	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	183.72	36.78	25.01	5.89	10.85	9.38	4.05	2.76
medial frontal gyrus, adult, donor10258	10368-105F8	102.30	25.41	7.94	3.18	4.13	3.81	1.59	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	342.04	53.31	13.65	6.40	4.69	6.82	6.82	2.99
medial temporal gyrus - adult, donor10196	10183-103D3	208.91	44.55	9.79	7.09	5.57	12.66	24.98	7.76
medial temporal gyrus, adult, donor10252	10156-103A3	200.98	41.38	35.87	9.34	10.40	12.31	6.37	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	71.27	53.94	5.78	7.71	5.78	3.85	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1435.36	545.44	559.79	229.66	430.61	43.06	129.18	114.83
medial temporal gyrus, newborn, donor10223	10353-105E2	138.91	20.46	3.23	1.79	2.15	3.23	1.08	2.87
medulla oblongata - adult, donor10196	10174-103C3	116.17	22.71	7.79	4.54	5.84	3.24	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	171.37	32.66	18.42	5.26	6.50	6.19	3.56	2.79
medulla oblongata, adult, pool1	10038-101F2	75.26	21.79	3.10	0.49	1.47	1.39	0.82	0.41
medulla oblongata, newborn, donor10223	10361-105F1	107.97	16.32	6.25	2.43	2.08	4.51	1.74	0.35
medulloblastoma cell line:D283 Med	10838-111E1	319.72	35.43	32.33	20.15	14.17	13.73	10.63	6.86
medulloblastoma cell line:ONS-76	10759-110E3	157.12	13.21	7.09	2.81	2.81	2.20	1.10	1.83
melanoma cell line:COLO 679	10514-107E1	148.63	12.79	3.16	1.44	2.16	1.44	1.01	0.86
melanoma cell line:G-361	10465-106H6	98.00	18.73	11.13	5.70	7.33	2.99	3.26	3.26
meningioma cell line:HKBMM	10691-109F7	49.57	10.49	3.44	1.27	1.63	1.45	2.71	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	252.89	26.43	17.62	5.29	8.81	10.57	0.88	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	206.34	23.33	9.07	5.44	4.93	4.15	1.56	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	59.38	8.29	1.99	1.53	0.46	2.15	1.38	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	43.81	6.00	1.09	0.73	0.55	0.91	1.09	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	68.74	7.04	1.66	1.66	0.41	0.83	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	56.05	8.01	2.25	0.98	1.40	1.12	0.42	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	48.53	5.78	2.70	0.77	0.39	1.54	1.73	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	63.86	12.49	1.39	1.39	2.08	1.39	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	37.42	5.32	0.34	1.37	0.17	0.69	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	53.14	8.40	2.65	1.73	0.23	0.58	0.92	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	57.30	6.90	1.46	1.86	0.66	1.46	0.66	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	56.72	7.70	1.35	1.76	1.49	2.57	1.08	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	83.93	10.53	2.56	1.56	1.14	1.71	0.43	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	77.40	12.52	3.29	1.98	2.96	1.32	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	68.77	8.86	2.21	0.28	0.69	1.52	0.69	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	70.51	12.22	4.89	3.14	2.09	1.75	3.14	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	38.59	4.70	1.63	0.82	1.22	1.84	1.02	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	55.72	7.55	1.80	4.67	1.08	1.08	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.35	7.03	1.86	0.93	0.41	1.45	1.03	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	45.60	7.30	2.28	2.74	1.82	1.14	0.91	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	96.50	12.17	5.87	3.36	0.42	4.20	1.68	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	61.57	7.17	2.39	1.34	2.09	1.05	1.05	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	50.59	6.74	1.23	1.40	0.96	2.36	0.79	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	67.37	12.15	1.84	1.84	2.95	1.47	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	58.38	8.58	6.58	3.72	3.15	2.29	1.14	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	66.94	8.00	4.21	4.21	2.95	1.68	4.21	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	37.45	0.91	1.83	0.46	0.00	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	40.67	8.19	2.05	1.53	2.05	1.02	1.02	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.69	4.71	0.52	1.31	0.26	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	45.60	7.70	0.92	2.46	0.62	1.23	1.85	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	49.42	6.35	2.12	1.88	1.18	1.65	1.18	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.57	6.77	0.68	1.02	0.68	1.35	1.02	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	44.01	3.14	3.54	1.18	1.57	1.96	1.96	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	39.85	3.71	2.32	1.39	0.46	0.00	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	52.49	8.08	1.15	2.02	0.87	1.15	1.15	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	42.84	6.47	1.12	2.01	0.89	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	48.07	5.05	0.96	0.48	1.44	0.48	1.44	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	85.80	13.20	0.73	2.20	0.00	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	36.25	5.37	1.34	0.00	0.67	0.00	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	42.17	5.32	1.64	0.82	0.82	1.64	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	46.39	5.58	0.86	1.29	1.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	5.47	0.00	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	5.16	15.49	5.16	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	41.57	5.85	1.62	0.00	0.97	0.65	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	16.00	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	39.98	7.46	2.67	1.60	0.00	0.53	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	44.16	8.18	0.82	0.82	0.82	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.81	5.44	1.17	0.78	1.17	0.00	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	41.97	2.10	0.00	0.00	4.20	0.00	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	37.75	4.97	0.00	1.99	0.00	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	4.77	0.00	0.00	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.62	5.93	2.37	1.19	1.19	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	49.96	8.53	0.00	1.22	2.44	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	45.60	5.70	0.00	2.53	0.63	0.00	1.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	31.73	3.45	2.76	0.34	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	4.30	6.45	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	0.00	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00	0.00	6.89	0.00	3.44	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	21.19	2.85	1.63	0.81	0.41	0.00	1.63	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	4.77	0.00	2.38	0.79	1.59	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.99	2.95	1.77	2.36	0.00	2.36	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	28.05	4.68	0.31	0.62	0.62	0.31	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	2.67	0.00	4.01	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	4.73	1.18	0.00	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	5.14	12.84	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	33.04	5.51	1.38	0.69	0.00	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	31.17	5.94	4.45	1.98	0.49	0.99	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	24.67	1.12	1.12	0.00	1.12	0.00	1.12	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.17	3.18	2.54	3.18	4.45	0.00	1.91	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.51	4.03	0.81	0.00	0.40	0.40	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	0.00	4.36	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	0.00	1.27	0.00	2.53	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	6.07	1.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	4.52	0.00	4.52	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	3.29	0.82	0.82	1.65	2.47	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.56	5.95	0.20	0.00	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.66	6.17	0.97	0.97	0.32	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	26.48	3.06	0.00	4.07	2.04	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	122.25	12.38	1.55	0.00	0.00	1.55	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	158.05	32.84	5.20	0.47	2.83	3.78	0.94	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	129.04	19.23	5.33	2.09	3.24	0.93	1.62	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	98.29	4.27	8.55	17.09	8.55	0.00	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	83.12	9.35	2.67	4.52	2.47	5.03	2.36	1.34
mesothelioma cell line:Mero-25	10850-111F4	69.67	10.44	4.09	3.40	1.36	1.36	2.27	2.04
mesothelioma cell line:Mero-41	10851-111F5	131.53	22.74	7.82	6.85	5.87	4.40	3.18	2.69
mesothelioma cell line:Mero-48a	10852-111F6	92.78	11.07	5.98	3.76	3.54	2.21	2.66	1.77
mesothelioma cell line:Mero-82	10853-111F7	86.46	10.25	13.14	8.15	6.57	4.20	5.52	4.47
mesothelioma cell line:Mero-83	10854-111F8	102.81	12.77	8.68	4.94	4.43	0.68	2.04	3.23
mesothelioma cell line:Mero-84	10855-111F9	62.44	6.32	2.02	1.77	1.26	1.77	1.26	0.25
mesothelioma cell line:Mero-95	10856-111G1	96.07	11.18	4.35	2.90	2.69	1.04	2.28	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	63.11	9.61	5.63	3.98	2.32	1.99	1.99	2.48
mesothelioma cell line:NCI-H226	10846-111E9	76.20	7.06	6.52	3.62	1.63	2.90	1.81	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	75.67	14.18	5.81	3.76	3.42	2.05	1.54	1.20
mesothelioma cell line:NCI-H28	10845-111E8	120.11	30.79	8.91	4.58	5.34	4.07	3.56	5.09
mesothelioma cell line:No36	10857-111G2	77.31	12.72	4.24	2.61	3.26	2.28	2.61	2.94
mesothelioma cell line:ONE58	10858-111G3	87.79	10.03	9.21	2.98	2.71	3.25	2.98	1.35
migratory langerhans cells, donor1	11901-125F2	153.92	18.04	6.72	1.54	3.65	1.73	1.34	1.34
migratory langerhans cells, donor2	11902-125F3	111.74	17.10	2.56	0.73	0.98	0.61	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	162.61	21.90	4.31	3.41	3.59	1.44	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	89.13	4.57	6.53	6.53	4.57	5.55	7.84	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	42.60	1.70	2.12	1.70	0.85	0.85	1.91	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	136.83	11.75	6.45	1.61	3.69	2.07	0.46	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	78.02	12.75	3.04	1.90	0.57	1.33	1.33	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	281.62	41.58	9.98	4.25	4.07	2.59	2.96	1.29
myeloma cell line:PCM6	10474-106I6	75.71	10.48	6.72	4.94	2.17	2.17	1.98	1.78
myxofibrosarcoma cell line:MFH-ino	10600-108E6	135.45	5.58	11.16	1.52	1.52	2.54	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	129.45	15.89	4.51	5.30	3.53	2.35	1.77	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	46.35	8.80	0.56	0.78	0.45	0.33	0.11	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	58.61	10.52	0.22	0.07	0.22	0.29	0.44	0.44
nasal epithelial cells, donor2	12227-129F4	79.49	19.87	2.76	1.66	0.55	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	231.21	30.37	6.44	2.53	2.99	2.53	0.92	1.38
neuroblastoma cell line:NB-1	10539-107G8	423.56	75.77	9.17	5.80	6.74	4.49	5.05	2.25
neuroblastoma cell line:NBsusSR	10607-108F4	118.31	15.18	3.37	6.12	2.74	2.53	3.59	1.90
neuroblastoma cell line:NH-12	10555-107I6	187.66	20.50	9.88	8.94	4.29	4.85	3.73	5.40
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	308.63	37.72	30.13	16.13	14.00	22.54	13.28	7.83
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	91.70	13.30	3.96	3.80	2.22	2.85	3.01	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	117.94	7.45	5.43	3.82	3.62	2.62	2.01	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	183.74	12.72	12.72	1.91	3.18	5.09	1.27	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	77.99	9.32	2.40	0.80	0.00	0.27	0.53	0.27
neutrophil PMN, donor1	12133-128D9	119.00	29.75	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	159.37	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	161.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	351.60	40.25	20.97	7.61	10.65	4.40	6.60	4.06
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	162.50	41.63	0.80	0.00	0.00	3.20	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	45.21	7.69	2.56	0.64	1.60	0.96	1.28	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	62.01	8.41	4.20	2.36	1.31	3.42	2.10	0.53
nucleus accumbens, adult, pool1	10037-101F1	103.68	29.90	5.06	1.03	2.44	1.41	0.56	1.22
occipital cortex - adult, donor10196	10172-103C1	177.19	57.69	4.12	6.18	6.18	0.00	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	206.64	42.13	34.62	10.73	17.18	18.52	4.29	2.95
occipital cortex, newborn, donor10223	10355-105E4	161.59	27.30	1.82	1.82	1.82	5.46	0.36	1.46
occipital lobe, adult, donor1	10076-102A4	146.16	25.45	2.89	0.79	2.36	3.15	1.84	0.26
occipital lobe, fetal, donor1	10073-102A1	201.68	29.61	7.72	3.43	7.29	4.29	1.72	0.00
occipital pole, adult, pool1	10036-101E9	53.53	15.30	1.26	0.39	0.39	0.71	0.39	0.16
olfactory region, adult	10195-103E6	122.46	29.23	28.08	9.55	11.27	6.88	5.35	4.39
optic nerve, donor1	10277-104E7	154.08	46.02	6.00	0.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	80.76	12.19	3.87	1.59	1.37	0.34	1.94	1.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	136.97	16.21	4.67	2.47	0.41	1.37	0.96	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	106.67	12.53	9.14	6.10	4.06	3.05	5.42	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	165.75	12.13	7.62	4.85	4.39	4.50	5.89	3.35
osteoclastoma cell line:Hs 706.T	10704-109H2	54.68	7.94	2.35	0.88	1.47	1.18	0.29	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	210.23	16.82	6.54	0.93	2.80	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	128.08	15.48	3.82	2.12	2.97	1.48	1.06	0.64
ovary, adult, pool1	10020-101D2	116.53	20.00	5.94	1.40	2.88	1.48	2.10	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	80.48	7.15	3.30	2.20	0.73	2.75	0.55	1.10
pancreas, adult, donor1	10049-101G4	58.32	11.29	3.76	1.88	0.94	1.88	3.76	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	124.11	12.02	5.03	2.52	3.35	2.24	1.68	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	97.44	13.46	10.05	9.20	5.62	3.58	5.96	4.60
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	196.55	23.51	6.79	2.81	2.32	1.16	0.66	1.32
paracentral gyrus, adult, pool1	10035-101E8	92.25	28.01	5.58	1.28	2.56	1.37	1.19	0.92
parietal cortex, adult, donor10258	10373-105G4	116.71	45.51	8.07	9.54	2.94	0.73	2.20	1.47
parietal lobe - adult, donor10196	10171-103B9	121.32	29.15	21.63	5.64	7.52	0.00	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	176.72	34.49	35.63	6.56	11.97	15.68	3.71	1.14
parietal lobe, adult, pool1	10034-101E7	79.22	23.53	3.79	1.23	2.73	0.88	0.35	0.62
parietal lobe, fetal, donor1	10072-101I9	252.16	32.00	10.67	5.82	13.58	9.70	4.85	0.00
parietal lobe, newborn, donor10223	10356-105E5	177.58	28.41	9.72	2.99	3.74	3.74	2.24	1.50
parotid gland, adult	10199-103F1	71.53	9.87	5.55	0.62	1.23	1.23	0.62	1.23
penis, adult	10200-103F2	128.91	20.41	22.56	6.98	6.45	5.91	5.37	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	172.36	24.73	8.37	3.53	2.42	3.72	2.97	3.90
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	111.60	17.77	4.81	4.08	3.93	1.31	3.79	1.89
pineal gland - adult, donor10196	10179-103C8	109.65	25.80	12.26	0.00	3.23	3.87	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	230.96	50.34	22.50	3.55	8.88	4.74	3.55	0.00
pineal gland, adult, donor10258	10377-105G8	119.14	33.86	10.03	0.63	4.39	3.76	2.51	1.25
pituitary gland - adult, donor10196	10180-103C9	204.38	45.53	18.21	3.04	7.08	4.05	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	384.63	72.97	23.97	7.30	9.38	6.25	2.08	3.13
pituitary gland, adult, donor10258	10378-105G9	155.78	36.60	9.36	5.11	5.11	5.11	4.26	0.85
placenta, adult, pool1	10021-101D3	153.30	19.35	6.77	1.08	3.01	2.26	0.97	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	158.78	21.32	7.15	2.12	4.11	3.18	1.59	1.32
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	136.81	18.37	2.80	1.40	2.02	1.09	0.31	0.78
pons, adult, pool1	10033-101E6	123.94	36.58	9.04	2.41	3.27	2.07	1.20	0.52
postcentral gyrus, adult, pool1	10032-101E5	62.68	18.05	2.27	0.70	0.70	1.83	0.44	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	129.67	12.55	4.18	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	16.52	0.00	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	42.10	5.39	4.81	1.89	2.62	0.87	1.60	1.02
prostate cancer cell line:PC-3	10439-106E7	453.21	57.72	38.66	19.42	19.97	10.35	8.71	11.07
prostate, adult, pool1	10022-101D4	112.37	18.23	4.53	1.09	2.54	1.63	0.54	0.82
putamen, adult, donor10196	10176-103C5	179.17	50.99	20.30	8.50	7.79	8.73	4.49	2.83
putamen, adult, donor10252	10152-102I8	131.37	17.65	17.65	5.88	1.96	5.88	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	75.40	33.88	8.74	8.74	3.28	4.37	1.09	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	89.88	25.37	14.01	7.49	5.07	2.90	2.66	1.21
putamen, newborn, donor10223	10365-105F5	257.88	32.99	5.25	4.50	6.00	6.75	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	191.73	21.24	17.75	2.04	5.82	4.65	1.45	1.75
rectum, fetal, donor1	10067-101I4	193.35	29.21	15.30	2.78	11.13	8.35	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	107.27	16.54	3.82	1.27	2.12	1.06	1.48	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	110.59	36.04	12.84	6.21	9.94	7.04	5.80	4.56
retina, adult, pool1	10030-101E3	102.98	20.28	2.98	0.99	1.49	1.89	0.99	0.70
retinoblastoma cell line:Y79	10475-106I7	282.92	36.11	36.89	12.47	26.76	8.05	7.01	5.20
rhabdomyosarcoma cell line:KYM-1	10787-110H4	104.63	10.20	8.36	2.70	3.57	2.21	1.23	1.35
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	511.50	40.77	27.28	6.19	12.09	4.78	2.53	3.66
sacrococcigeal teratoma cell line:HTST	10695-109G2	97.76	9.85	1.52	0.76	2.27	5.30	1.52	0.00
salivary acinar cells, donor1	11771-123I7	86.27	9.39	8.90	4.21	4.69	1.94	2.27	1.46
salivary acinar cells, donor2	11772-123I8	77.24	8.81	7.71	4.41	1.38	1.24	1.51	1.79
salivary acinar cells, donor3	11773-123I9	121.82	11.92	25.82	2.65	3.97	8.61	1.32	1.99
salivary gland, adult, pool1	10093-102C3	68.06	14.30	2.29	0.00	0.00	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	114.33	18.30	4.55	2.53	2.45	2.95	1.69	1.60
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	110.97	18.81	4.94	3.17	2.35	3.41	1.53	1.06
seminal vesicle, adult	10201-103F3	248.13	35.45	29.10	8.99	8.99	7.41	4.76	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	171.02	21.86	7.77	6.80	3.40	3.89	4.37	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	44.54	7.55	1.01	1.76	0.50	0.75	0.75	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	75.26	9.03	2.01	1.00	1.00	3.01	3.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	120.62	14.37	7.25	5.51	3.90	5.78	5.64	4.57
signet ring carcinoma cell line:Kato III	10436-106E4	88.97	16.36	4.53	2.10	2.65	0.77	1.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	103.22	14.32	1.29	0.52	1.68	1.81	0.52	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	82.99	17.73	19.86	3.55	4.97	11.35	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	79.88	17.15	4.56	0.72	1.44	0.84	0.36	0.00
skeletal muscle, fetal, donor1	10066-101I3	89.45	10.05	6.03	3.02	2.01	0.00	3.02	0.00
skin, adult, donor1	10074-102A2	108.56	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	200.73	23.36	3.16	2.52	3.79	1.26	2.52	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	91.05	11.67	4.34	1.00	2.67	1.33	0.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	272.34	26.48	31.84	16.71	15.76	15.76	10.09	8.51
small cell lung carcinoma cell line:DMS 144	10841-111E4	163.26	20.24	2.70	1.54	2.51	4.24	1.54	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	217.74	43.51	8.08	1.98	2.14	3.13	1.65	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	292.10	55.17	33.94	14.48	12.55	9.65	5.63	5.95
small cell lung carcinoma cell line:WA-hT	10562-108A4	117.02	11.11	4.79	3.92	3.49	3.70	1.74	2.40
small intestine, adult, pool1	10024-101D6	151.33	26.28	6.57	1.91	3.11	2.87	0.84	0.72
small intestine, fetal, donor1	10064-101I1	107.86	15.97	13.27	4.18	7.62	3.69	6.63	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	123.10	26.16	9.75	6.15	6.67	3.08	6.15	1.54
smooth muscle, adult, pool1	10048-101G3	124.58	18.35	8.01	3.10	4.65	2.07	2.84	1.29
somatostatinoma cell line:QGP-1	10781-110G7	148.48	22.78	7.77	0.54	2.41	3.48	0.27	1.07
spinal cord - adult, donor10196	10181-103D1	185.36	33.49	19.04	5.74	7.57	9.86	8.03	2.98
spinal cord, adult, donor10252	10159-103A6	221.58	45.34	15.38	6.31	7.49	1.97	4.73	2.37
spinal cord, adult, donor10258	10369-105F9	143.89	40.82	24.90	5.53	1.38	5.53	2.08	2.08
spinal cord, fetal, donor1	10056-101H2	134.77	26.22	9.76	1.22	3.05	0.00	2.44	0.00
spinal cord, newborn, donor10223	10359-105E8	239.25	27.55	14.69	3.21	7.35	8.27	1.84	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	67.96	7.02	2.84	0.75	0.90	1.94	0.45	1.05
spleen, adult, pool1	10025-101D7	160.69	23.24	7.93	2.86	4.41	1.87	0.77	0.99
spleen, fetal, pool1	10044-101F8	116.64	14.62	1.35	0.24	0.48	1.35	0.40	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	176.59	29.81	9.83	5.59	3.11	1.45	4.45	3.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	166.14	18.04	10.44	2.28	6.08	4.56	1.33	1.71
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	112.87	9.44	9.44	5.24	5.59	6.29	7.34	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	182.56	12.90	7.04	3.52	3.91	1.95	2.74	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	95.56	14.63	6.42	2.03	4.50	2.25	1.80	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	154.61	14.40	6.78	3.81	2.97	3.81	3.81	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	175.15	20.73	8.04	4.65	3.38	4.65	0.42	1.27
stomach, fetal, donor1	10062-101H8	181.56	17.09	2.14	0.00	4.27	4.27	0.00	0.00
submaxillary gland, adult	10202-103F4	137.29	19.37	7.41	3.99	1.71	1.71	3.42	0.57
substantia nigra - adult, donor10196	10178-103C7	1194.03	217.10	2279.51	651.29	1628.22	325.64	162.82	54.27
substantia nigra, adult, donor10252	10158-103A5	174.89	30.53	19.11	6.02	6.65	8.10	5.61	2.49
substantia nigra, adult, donor10258	10371-105G2	108.11	29.48	18.62	4.14	5.69	6.21	0.52	2.59
substantia nigra, newborn, donor10223	10358-105E7	127.18	23.32	4.95	3.53	1.41	9.19	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	292.08	36.45	25.45	15.13	15.36	7.80	8.71	6.42
temporal lobe, adult, pool1	10031-101E4	69.77	15.51	1.36	0.25	0.76	0.93	0.59	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	190.89	27.78	12.82	4.99	8.55	2.85	4.99	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	148.12	29.45	13.19	4.40	4.40	4.83	1.32	1.32
tenocyte, donor1	11763-123H8	41.89	6.63	2.44	3.14	0.00	2.79	4.19	0.70
tenocyte, donor2	11765-123I1	30.14	7.25	2.67	1.14	1.14	1.91	1.14	1.14
tenocyte, donor3	11768-123I4	27.43	4.08	2.59	4.08	0.74	1.11	2.97	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	281.62	35.18	17.34	6.12	8.50	8.84	4.76	3.06
teratocarcinoma cell line:NCR-G1	10798-110I6	160.93	10.94	9.09	3.85	4.01	3.85	2.47	1.85
teratocarcinoma cell line:PA-1	10807-111A6	169.08	19.68	10.69	3.72	4.18	3.56	3.41	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	222.79	32.88	11.68	3.05	6.22	4.70	2.16	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	356.62	41.22	11.72	7.56	5.29	7.56	4.54	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	377.36	47.44	17.45	5.13	7.96	7.96	2.18	3.16
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	285.64	26.71	25.73	14.98	8.14	15.31	20.84	9.45
testis, adult, pool1	10026-101D8	160.09	25.66	5.80	2.36	2.47	2.36	1.83	0.97
testis, adult, pool2	10096-102C6	170.06	29.77	22.55	8.12	11.73	8.57	6.32	2.26
thalamus - adult, donor10196	10168-103B6	206.45	45.26	18.77	3.31	5.52	5.52	1.10	2.21
thalamus, adult, donor10252	10154-103A1	204.11	41.26	18.91	9.22	9.22	6.56	5.16	5.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	55.43	47.73	16.94	7.70	4.62	4.62	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	67.19	14.00	5.11	2.47	3.46	5.27	2.96	0.99
thalamus, newborn, donor10223	10366-105F6	159.94	16.11	6.33	3.45	4.03	4.03	1.73	0.58
throat, adult	10209-103G2	148.05	22.97	4.49	0.25	1.75	0.75	1.50	0.00
throat, fetal, donor1	10061-101H7	126.76	17.06	7.31	2.74	4.57	2.13	3.96	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	172.30	19.48	9.54	3.97	4.77	3.97	1.79	1.19
thymus, adult, pool1	10027-101D9	225.67	25.15	7.16	2.29	4.08	2.58	1.69	0.80
thymus, fetal, pool1	10043-101F7	240.64	30.13	7.90	2.91	3.74	2.81	1.97	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	115.81	11.70	1.86	2.26	1.73	1.20	1.46	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	100.16	19.28	5.73	3.63	2.93	3.07	1.96	1.68
thyroid, adult, pool1	10028-101E1	94.43	19.22	4.39	1.40	2.05	1.03	0.84	0.28
thyroid, fetal, donor1	10060-101H6	122.87	29.53	13.45	5.54	5.80	6.33	3.69	3.16
tongue epidermis (fungiform papillae), donor1	10288-104F9	169.38	30.80	49.27	0.00	9.24	18.48	0.00	0.00
tongue, adult	10203-103F5	116.99	19.07	7.68	4.42	5.12	1.40	2.79	1.63
tongue, fetal, donor1	10059-101H5	78.82	13.01	9.06	2.36	1.58	1.97	4.73	1.18
tonsil, adult, pool1	10047-101G2	131.03	17.43	1.10	0.90	1.10	1.50	0.40	0.30
trachea, adult, pool1	10029-101E2	124.50	18.90	5.24	1.55	1.47	1.15	0.74	0.65
trachea, fetal, donor1	10058-101H4	125.80	23.08	10.39	3.46	4.62	2.69	3.85	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	87.15	13.46	6.38	4.25	3.90	0.71	1.77	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	210.94	23.81	4.26	1.82	2.33	1.82	1.11	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	159.35	24.13	9.56	5.64	9.87	4.54	4.39	3.29
tridermal teratoma cell line:HGRT	10694-109G1	81.81	9.51	5.71	1.90	9.51	13.32	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	72.71	13.46	2.71	1.27	1.35	1.86	0.85	1.02
umbilical cord, fetal, donor1	10057-101H3	75.11	10.43	10.43	0.00	4.17	6.26	2.09	4.17
uterus, adult, pool1	10100-102D1	142.82	22.52	2.05	0.68	0.68	1.54	0.85	1.19
uterus, fetal, donor1	10055-101H1	135.15	15.87	7.17	5.12	4.61	1.02	3.58	0.51
vagina, adult	10204-103F6	99.51	20.68	3.23	1.29	2.58	2.58	1.29	0.00
vein, adult	10191-103E2	143.36	19.07	7.01	2.41	2.63	2.19	2.85	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	88.92	15.49	7.48	4.54	1.87	1.34	2.67	2.94